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Abstract
Single-cell RNA-sequencing (scRNA-seq) involves the measurement of gene expression from iso-
lated single cells, with the potential to illuminate cellular heterogeneity within complex tissue sam-
ples. However, scRNA-seq data are subject to a large number of technical effects. In this work, we
present two approaches that can be applied for identifying technical effects in scRNA-seq data in
pursuit of the ultimate aim of removing these effects in downstream analyses.
The first project introduces different concepts of stably expressed genes with respect to true
biological expression. Different classes of stably expressed genes may capture different techni-
cal effects, assisting in the removal of these technical effects and increasing the biological inter-
pretability of later results. We define different notions of stability explicitly and organize gene sets
by structure to identify gene sets that are systematically enriched with different classes of stably
expressed genes. We find that genes associated with the cytosolic ribosomal structure are enriched
with genes that are stably expressed in proportion to the total RNA content of a cell. The cytosolic
ribosomal genes can serve as a foundation for a set of negative control genes incorporated into
normalization procedures to remove some technical effects associated with cell size.
The second project describes a procedure to estimate the efficiency with which genes are cap-
tured in scRNA-seq experiments. Unique molecular identifiers (UMIs) tag molecules before am-
plification and allow for later deduplication of reads originating from the same original molecule.
Ordinarily, we are interested in the number of UMIs present to enumerate the gene expression of
a cell. We consider the information typically discarded during deduplication by measuring the
number of reads captured for each unique molecular identifier (rUMI). Features of reliable detec-
tion and genes with those features can be identified from the rUMI distributions and applied to
downstream analyses, correcting for additional technical effects.
Specifically, we estimate the unobserved proportion of molecules that are not captured (0
rUMI) from the observed distribution of rUMI by extrapolation. We propose a framework for
three possible zero-truncated integer-based distributions to model the rUMI distribution. Based on
the models, we identify five estimators of the true proportion of reads that are lost during the exper-
iment and result in 0 rUMIs. We derive and simulate asymptotic features of these estimators under
different conditions and perturbations motivated by scRNA-seq data. We apply our estimators to a
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scRNA-seq dataset, noting molecule characteristics like the proportion of GC bases in a transcript,
that suggest reliable detection.
Together, these projects provide two approaches to identifying technical biases in scRNA-seq




Single-cell RNA-sequencing (scRNA-seq) was first published in 2009, with many experimental
and analytical advances developed since the first experiment. Scientists can capture thousands
of cells at a low cost with droplet-based cell isolation protocols or can select individual cells for
placement in well-based protocols. From each of these single cells, mRNA transcripts are captured,
amplified, sequenced, and aligned, providing measures of the gene expression for a given cell.
Errors can be introduced during any of these steps, and technical variation is fundamentally a
problem in scRNA-seq data.
Various advances, both biological and analytical, have been introduced to correct and adjust
for technical effects in scRNA-seq data. The introduction of unique molecular identifiers (UMIs)
is one biological advancement, where the UMI serves as a tag used to deduplicate reads origi-
nating from amplification. External spike-ins provide another experimental means of measuring
some of the technical effects in scRNA-seq experiments. Analytically, various procedures and nor-
malizations have been developed and proposed to remove effects associated with biological and
technological characteristics, including cell cycle and batch effects.
In the biologically motivated work presented here, we identify a set of genes and characteristics
of genes that help capture some of the technical biases in scRNA-seq experiments and could help
to normalize scRNA-seq data for technical effects. Specifically, we examine stably expressed
genes and reliably detectable genes. The stably expressed genes could serve as negative controls in
normalization procedures. Additionally, we can adjust a gene’s observed expression measurement
from its estimated proportion of molecules lost to technical effects. A low proportion of molecules
estimated to be lost during a scRNA-seq experiment due to technical effects could be used to define
reliably detectable genes.
In Chapter 2, we explore the concept of stable expression of genes. First, we define stably ex-
pressed genes; we argue that the concept of stable expression at the single cell level is ambiguous
and provide different notions of stability. We propose measures with which to assess the stable
expression of a gene. Further, we propose a model for measured expression at the single cell level
and apply that model in the interpretation of the results from our stability measures. We explore
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gene sets determined by the cellular structures in which a gene’s final product is associated, identi-
fying the cytosolic ribosomal genes as being enriched in proportionally stably expressed genes in
scRNA-seq experiments performed by multiple labs using both Fluidigm C1 and 10x scRNA-seq
platforms. Additionally, we find similar results from an analysis of bulk tissues gathered as part
of the GTEx project, supporting that the cytosolic ribosomal genes are in fact enriched with pro-
portionally stably expressed genes. We also generate a database of gene information summarizing
various analyses for use by researchers in further refining sets of genes for later normalization.
Supplementary information and analyses are found in Chapter 6.
In Chapter 3, we define rUMI as a measure of reliable detection for genes in scRNA-seq.
The number of reads associated with a UMI (rUMI), which typically is removed during the dedu-
plication of scRNA-seq results, can also provide a measure of the technical biases present in a
scRNA-seq experiment. We propose an estimator for the parameter from a zero-truncated Poisson
distribution. We apply this estimator to rUMIs obtained from a scRNA-seq experiment, exploring
the relationship between different variables and rUMI. We find that an imbalance of GC bases
compared to AT bases in both the full length of the transcript and the first half of a transcript re-
sults in less reliable detection of a gene. Chapter 7 provides supplementary information, including
a generalized linear model to estimate rUMI.
Chapter 4 further develops estimators based on the zero-truncated distribution introduced in
Chapter 3 and two additional zero-truncated distributions described in Chapter 4. We motivate the
three special cases that describe potential rUMI distributions. We then propose five estimators for
the unobserved probability that an rUMI is equal to zero, i.e. the proportion of molecules that at-
tach to a UMI but fail to be captured as a read; these molecules are lost due to technical errors. We
describe characteristics of these estimators analytically when possible and by simulation. We apply
our estimators to subsets of the data with various transcript attributes to observe the relationship
between transcript attributes and the unobserved probability of losing a transcript. We find that the
robust estimator based on a zero-truncated Poisson distribution introduced in Chapter 3 performs
well under most conditions but is rarely optimal. We also explore the relationship between the es-
timated expression level of a gene and the technical loss of that gene, finding that lowly expressed
genes are estimated to experience marginally more technical loss. Chapter 8 provides supplemen-
tary theoretical results derived from estimator properties and additional evaluations of estimator
performance from simulations.
Finally, Chapter 5 summarizes the findings of Chapters 2, 3, and 4 and suggests future avenues
for continued exploration in this area.
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Chapter 2
Stably Expressed Genes in Single-Cell RNA-Sequencing
2.1 Abstract
Motivation: In single-cell RNA-sequencing (scRNA-seq) experiments, RNA transcripts are ex-
tracted and measured from isolated cells to understand gene expression at the cellular level. Mea-
surements from this technology are affected by many technical artifacts, including batch effects. In
analogous bulk gene expression experiments, external references, e.g., synthetic gene spike-ins of-
ten from the External RNA Controls Consortium (ERCC), may be incorporated to the experimental
protocol for use in adjusting measurements for technical artifacts. In scRNA-seq experiments, the
use of external spike-ins is controversial due to dissimilarities with endogenous genes and uncer-
tainty about sufficient precision of their introduction. Instead, endogenous genes with highly stable
expression could be used as references within scRNA-seq to help normalize the data. First, how-
ever, a specific notion of stable expression at the single cell level needs to be formulated; genes
could be stable in absolute expression, in proportion to cell volume, or in proportion to total gene
expression. Different types of stable genes will be useful for different normalizations and will need
different methods for discovery.
Results: We compile gene sets whose products are associated with cellular structures and record
these gene sets for future reuse and analysis. We find that genes whose final product are associated
with the cytosolic ribosome have expressions that are highly stable with respect to the total RNA
content. Notably, these genes appear to be stable in bulk measurements as well.
Availability: The gene set database is available online through github (github.com/johanngb/sc-
stable).
2.2 Introduction
Single-cell RNA-sequencing (scRNA-seq) experiments measure gene expression at the cellular
level, capturing details at a resolution previously not possible. However, challenges arise due to
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unwanted variation that scRNA-seq experiences. Some sources of unwanted variation include read
depth, capture efficiency, amplification biases, batch effects, and cell cycle [Hicks et al., 2018;
Phipson et al., 2017; Lun and Marioni, 2017; Dabney and Meyer, 2012; Kolodziejczyk et al.,
2015]. Methods have been developed to remove some sources of unwanted variation, often using
certain sets of reference genes to aid in removing either specific or general effects. For example,
Chen and Zhou [2017] use Bayesian methods to identify control genes that are unassociated with
a factor of interest and adjust the target genes based on the control genes. Buettner et al. [2015]
use genes that have been annotated as associated with the cell cycle to remove cell cycle effects
from the data. Both Brennecke et al. [2013] and Grün et al. [2014] propose using external spike-in
references to remove some of the technical noise present in the data. Finally, Lin et al. [2019b]
propose using stably expressed genes as a form of negative controls to remove unwanted variation
using a procedure called scMerge.
Commercially generated, synthetic, external spike-in references (often External RNA Controls
Consortium (ERCC) spike-ins) can be used in bulk gene expression experiments [Baker et al.,
2005; Jiang et al., 2011; Risso et al., 2014; Pine et al., 2016]. The ability to incorporate external
spike-in references in scRNA-seq varies based on the cell isolation protocol. Spike-ins are not
typically included in droplet-based isolation protocols but can be in plate- and well-based isolation
methods including the Fluidigm C1 system [Macosko et al., 2015; Bacher and Kendziorski, 2016;
Lun et al., 2016; Tung et al., 2017].
Limitations to the use of spike-ins are not limited to scRNA-seq contexts. A critique in both
single cell and bulk experiments is that the spike-ins possess qualities that are dissimilar to en-
dogenous genes [Grün and vanOudenaarden, 2015; Tung et al., 2017]. Spike-ins are designed to
exhibit artificially wide ranging characteristics, like length and proportion of guanine and cytosine
bases in the nucleic acid sequence, in order to understand how these characteristics might affect
downstream results. Specific to scRNA-seq, the quantity of solution added for each cell is much
smaller, so minor pipetting errors (with the Fluidigm C1 system) or other volume errors affect re-
sults much more than with a larger quantity of solution [Tung et al., 2017]. The technical challenge
of accurately introducing and measuring a smaller volume of spike-ins reduces their effectiveness
as negative controls in scRNA-seq [Robinson and Oshlack, 2010].
Endogenous genes that are reasonably stably expressed have been proposed for use in nor-
malization of microarray data [Eisenberg and Levanon, 2003, 2013; Gagnon-Bartsch and Speed,
2012]. However, it is unclear that the single cell expression of these same genes exhibit the same
stability as in bulk experiments. For example, a gene may be expressed with a bursting mechanism,
increasing its variability [Jiang et al., 2017; Suter et al., 2011; Fukaya et al., 2016]. Bulk expres-
sion data might identify the gene as stably expressed, but that same classification at the single cell
level would be inappropriate.
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There is a need to discover single cell-specific stably expressed genes. Lin et al. [2019a]
propose a method of creating an index at the single cell level for generating a set of stably expressed
genes across all cell conditions. Desired characteristics of stably expressed genes from Lin et al.
[2019a] include a distribution with a small proportion of measurements with low values and a small
variance among the measurements with high values as estimated from parameters of a Gamma-
Gaussian model.
One prominent feature of scRNA-seq data is the presence of a large number of zero measured
expressions for genes, sometimes called dropouts. The prevalence of zero counts can reach 90% in
some datasets. Ideally, any stably expressed genes used for normalization would also be reliably
detected and have a relatively low proportion of zero counts.
The goals of this Chapter are: (1) to clarify the notion of “stable expression” at the single
cell level, and in particular to define multiple such notions, (2) to propose a method in which to
identify a set of genes that exhibit stable expression, (3) to organize sets of genes based on the
cellular component with which the final gene product is associated, and (4) to suggest the set of
cytosolic ribosomal genes as stably expressed with respect to total RNA content.
2.3 Approach
2.3.1 Notions of Stability
We first consider explicitly what it means for a gene to be stable. The idea of stable expression
has previously been addressed either implicitly or without much elaboration. However, the notion
of stability at the single cell level is inherently ambiguous and requires a precise definition. In the
following paragraphs we consider multiple notions of stability. Importantly, these notions refer to
the true gene expressions within a cell, not to the measured expressions (data), a point we return to
below.
One notion of a stably expressed gene would be that the gene is expressed at a constant ab-
solute level. In other words, the number of RNA molecules present within each cell should be
approximately constant, e.g., each cell has about 10 RNA molecules of that gene. We refer to this
notion of stability as “absolute stability.” Genes that are absolutely stable could replace the external
spike-ins, as they are expected to be present at a fixed absolute amount in each cell. Like spike-ins,
these genes could be used to pick up certain technical effects, such as reaction efficiency.
A second notion of stable expression would be that genes are expressed at a constant proportion
with respect to cell volume; that is, they are stable in terms of concentration. We refer to this
as “stable in concentration.” In addition to picking up technical effects, genes that are stable in
concentration could also pick up and adjust for effects that are associated with cell size.
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Yet another notion of a stably expressed gene would be that the gene is expressed at a constant
proportion with respect to the total RNA content of the cell from all genes. We refer to this as “sta-
ble in proportion to total RNA content,” or, when it is clear from context, simply as “proportionally
stable.” In practice, we expect that sets of genes that are stable in concentration will be similar to
sets of genes that are proportionally stable, provided that total RNA scales with cell size; in that
case, both are likely to pick up cell size effects.
The notions of stability described above are biological in nature; they make no reference to
measurements of gene expression, such as those provided by scRNA-seq data. In a hypothetical,
extremely high quality dataset, these biological notions of stability would map clearly to features
of the data. An absolutely stable gene would have a small coefficient of variation in terms of raw
counts; a proportionally stable gene would have a small coefficient of variation after dividing the
raw counts by total cell count.
Real data, however, is subject to technical factors that strongly affect the observed counts. In
particular, some factors, like reaction efficiency, have a strong global effect on all counts for a given
cell, effectively introducing a random scaling factor for each cell. Thus in real data, genes that are
absolutely stable will not necessarily appear particularly stable in terms of their raw counts.
To further clarify these ideas, consider the following model:
yij ∼ Pois(eijtI(j∈endogenous genes)i u
I(j∈spike-ins)
i vjwij). (2.1)
Here yij represents the measured expression (read count) for gene j in cell i and eij the true ex-
pression (number of transcripts) of gene j in cell i. Technical factors that affect endogenous genes
and spike-ins are included in the terms ti and ui, respectively. A gene-specific scaling factor vj
could capture factors including amplification biases, and wij is an error term. Vallejos et al. [2017]
provide a model for the expected read count as a function of the expression level and a cell-specific
scaling factor that incorporates features such as capture efficiency and amplification efficiency
(Box 1). Our model here is similar, with the expected read count corresponding to our Poisson pa-
rameter above, except that we have explicitly included one cell scaling factor for endogenous genes
(ti) and another for spike-ins (ui). Some cell-specific factors will only affect endogenous genes
(e.g., lysis efficiency), while others will affect only spike-ins (e.g., minor variations in the quantity
spiked-in). Other factors (e.g., amplification, sequencing) are experienced by both endogenous
genes and spike-ins and will therefore appear in both ti and ui. Note, importantly, that for the
spike-ins to be useful for normalization purposes, the t and u should be reasonably correlated.
We can represent cell totals in terms of Model 2.1. Specifically, let the endogenous total of a
cell beEi,endo =
∑
k∈endogenous eik. Likewise, let Yi,endo =
∑
k∈endogenous yik. Similarly, we denote the
ERCC total expression as Ei,ERCC =
∑
k∈ERCC eik and the measured total expression as Yi,ERCC =∑
k∈ERCC yik.
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The notions of stability defined above map onto terms in Model 2.1. A gene j that is abso-
lutely stable would appear with a small coefficient of variation in ej , the true expressions of that
gene. However, yj may be quite variable due to the variation in t, obscuring the absolutely stable
expression from ej .
Additionally, we can illustrate proportional stability from Model 2.1. We denote the propor-
tional expression of a gene as pij = eij/Ei,endo, or the expression of gene j in cell i divided by
the total expression of cell i. Genes that are proportionally stable would appear with a small co-
efficient of variation in the vector pj . The cell scaling factor ti in Model 2.1 could plausibly be
roughly proportional to the cell volume or Ei,endo. Thus, genes with small coefficient of variations
in yij/Yi,endo could be approximately proportionally stably expressed or stable in concentration.
Normalizing the raw counts by the total cell count, Yi,endo can help adjust for the scaling factor
t in Model 2.1, and such normalizations are common (e.g., RPKM is a variant of this1). After
normalizing by total cell count, the notion of stability that is most relevant is proportional stability.
That is, genes that appear stable in the normalized data would be those genes that are proportionally
stable, and genes that are in truth absolutely stable would not necessarily appear stable in the data.
Indeed, for this reason – that normalization by total cell count is effectively necessary to adjust
for cell-specific scaling factors, but that normalization by cell total also obscures absolutely stable
expression – absolutely stable genes are especially difficult to identify. Note also that similar
comments apply to efforts to discover stably expressed genes in bulk tissue.
Importantly, note that a stably expressed gene can be viewed as the opposite of a differentially
expressed gene or a highly variable gene. That is, the notion of stability, whether implicit or
explicit, also implies the notion of instability or variability. In practical terms, the normalization
that is applied to the data may not simply “clean” the data, but also alter the biological interpretation
of the data, and determine which biological questions can (and cannot) be answered by the data.
For example, normalizing the data against a set of absolutely stable genes would allow one to
identify “absolutely differentially expressed genes,” while normalizing the data against a set of
proportionally stable genes would allow one to identify “proportionally differentially expressed
genes.” These two sets of differentially expressed genes could be quite different. Thus, finding sets
of genes that exhibit different notions of stability would allow for different types of normalization,
which provide different biological insights.
1RPKM is defined as [(gene count) / (total cell count)] * [1,000,000 / (length of gene in KB)]. The [1,000,000 /
(length of gene in KB)] term is a rescaling to aid interpretability and adjust for gene length. For a given gene this
rescaling is identical across cells, and thus a gene that appears stable in terms of [(gene count) / (total cell count)] will
also appear stable in terms of RPKM.
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2.3.2 Localization of Stable Genes
The final product of a gene (protein, ribosomal RNA, etc.) is often localized to specific structure(s)
within the cell, e.g., nucleus, cell membrane, etc. We may therefore associate a gene with the
location(s) where that gene’s final product(s) are active.
We hypothesize that certain structures may be enriched with genes that are absolutely stable,
while other structures may be enriched with genes that are stable in concentration. For example,
because each cell has one nucleus, there may be a set of nuclear genes that are constant in absolute
expression. In contrast, there may be a set of genes enriched in the cytosol that are reasonably
constant in concentration.
The hypothesis that structures may be important for identifying stably expressed genes moti-
vates our analysis. We create gene sets for each cell structure and assess the stability of each gene
set as a whole.
2.4 Methods
2.4.1 Mapping Genes to Cell Structures
The Gene Ontology Consortium maintains a database that specifies the cellular component(s) with
which each gene’s final product, often a protein, is associated [Xin et al., 2016; Wu et al., 2013].
Many of the annotations provided by the Gene Ontology Consortium are highly detailed (e.g.,
“mitochondrial respiratory chain complex I”); we coarsen the 1,629 unique cellular components
into ten categories corresponding to major cellular structures; see Section 6.2.1 for details. The
ten categories are: nucleus, endoplasmic reticulum, Golgi body, cytoplasm, membrane, ribosome,
mitochondria, mitochondrial ribosome, ribonucleoprotein complex, and cytosolic ribosome. The
Gene Ontology Consortium returns zero to 41 cellular components for each gene we consider.
Therefore, we allow a single gene to be associated with more than one cellular structure, and some
genes are not associated with any structures. We will refer to the sets of genes as “nuclear genes,”
“cytoplasm genes,” etc. Thus, nuclear genes are those genes whose final products are associated
with the nucleus or some subpart of it, etc.
Table 2.1 shows the distribution of the cell structures amongst different gene sets within our
scRNA-seq data. Note that genes can be associated with more than one structure; while the cytoso-
lic ribosomal genes are associated with the cytosolic ribosome, they are not exclusively associated
with that structure. We also show the distribution of genes of Eisenberg and Levanon [2003] and
of Lin et al. [2019a].
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Table 2.1: Distribution of Cell Structures Amongst Different Sets of Genes
Structure All Genes E & L Lin et al. Cyto. Ribo.
Number of Genes 8,605 470 967 103
Nucleus (4,280) 50% 57% 70% 68%
Endoplasmic Reticulum (934) 11% 14% 10% 16%
Golgi Bodies (850) 10% 11% 9% 2%
Cytoplasm (2,600) 30% 36% 32% 32%
Ribosome (177) 2% 8% 8% 100%
Mitochondria (1,187) 14% 22% 14% 13%
Mitochondrial Ribosome (75) 1% 1% 1% 4%
Ribonucleoprotein (185) 2% 5% 6% 17%
Membrane (3,160) 37% 52% 36% 64%
Cytosolic Ribosome (103) 1% 7% 4% 100%
Table 2.2: C1 Data Information
GEO sample Author Tissue type Number cells Number genes
77288 Tung et al. [2017] Stem cells 2,592 20,425
84686 Das et al. [2017] T cells 96 25,462
79130 Arguel et al. [2017] Kidney 47 18,730
89235 Arguel et al. [2017] Kidney 76 17,594
89236 Arguel et al. [2017] Nasal epithelium 96 16,160
89237 Arguel et al. [2017] Nasal epithelium 96 15,670
2.4.2 Expression Data
2.4.2.1 Fluidigm C1 Data
We downloaded six datasets containing human cells processed by three different lab groups and
from four different tissue types from Gene Expression Omnibus [Edgar et al., 2002; Arguel et al.,
2017; Das et al., 2017; Tung et al., 2017]. We selected these datasets because they were conducted
with the Fluidigm C1 platform with human cells and included ERCC spike-ins. Note that four of
these datasets were generated by one lab while performing an experiment [Arguel et al., 2017].
Note also that all but one of these datasets make use of unique molecular identifiers (UMIs) [Kiv-
ioja et al., 2012]. We filter to the genes that are expressed with at least one UMI in all datasets to
ensure that genes are expressed in a wide variety of tissue types and to compare the datasets more
directly. Table 2.2 provides general information on each of these datasets.
One cell was removed from each of GSE89236 and GSE89237. These cells had two and zero
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Table 2.3: 10x Data Information
Sample Tissue type Number cells Number genes
Fresh 68k PBMCs Blood 68,579 20,387
AML027 Pre-transplant BMMCs Bone marrow 3,933 15,705
Jurkat Cells T cells 3,258 17,753
293T Cells Kidney (embryonic) 2,885 18,760
293T Cells from mixture Kidney (embryonic) 482 16,715
3T3 Cells from mixture Fibroblast 538 13,573
UMIs measured, respectively.
GSE77288 reported genes by Ensembl identifiers, which we transformed to gene names with
getGenes from mygene to match the other five datasets [Wu et al., 2013; Xin et al., 2016]. We
removed genes that could not be identified with a gene name, and summed Ensembl identifiers
associated with the same gene name.
2.4.2.2 10x Data
Additionally, we downloaded data from five experiments generated on the 10x platform from the
10x website [Zheng et al., 2017]. We selected datasets that appeared to have a large number of
cells and a fairly high sequencing depth, providing additional tissue types and heterogeneity. Note
that all datasets consist of human cells except the 3T3 cells, which are mouse cells. Note also that
Jurkat, 293T, and 3T3 cells are cell lines, and the PBMC and BMMC cells were obtained from live
samples. We analyzed the Gene / cell matrix (filtered) using gene names for the specified datasets,
including only those genes with at least one read. Table 2.3 summarizes characteristics of the 10x
datasets.
For the Fresh 68k PBMCs dataset, we randomly sampled 20,000 cells to make the calculations
more computationally tractable. Additionally, we subsetted the genes to those that were considered
in our Fluidigm C1 analyses and expressed in each of the four 10x datasets, resulting in 8,172
genes.
2.4.3 Zero Counts
Sometimes called dropouts, zero counts occur when no copies of a given gene’s transcripts are
measured for a specific cell. Zero counts are a prominent feature of scRNA-seq data. For the six
Fluidigm C1 datasets, the proportion of zeros ranges from 41% to 82% of the entries. Ideally,
any stably expressed genes that we discover would have a low proportion of zero counts. Figure
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Figure 2.1: The median proportion of zero counts within each gene set, with symbols representing
the different Fluidigm C1 datasets. Cytosolic ribosomal genes have an especially low proportion
of zero counts across datasets.
2.1 displays the proportion of zero counts for each of the structural gene sets from each dataset.
The proportion of zero counts is smaller for the ribosomal genes and dramatically smaller for the
cytosolic ribosomal genes.
2.4.4 Absolute Stability
Genes that are absolutely stable would ideally appear stable in the data in terms of raw counts;
however, as noted in Section 2.3, due to technical factors that result in strong variation in library
size from well to well, simply looking for genes that are stable in terms of raw counts is not a
feasible way to discover absolutely stable genes. Instead, we leverage the stable absolute “expres-
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sion” of the ERCC spike-ins and attempt to find absolutely stable genes by looking for those genes
that have a high correlation with the ERCCs. We assume that the ERCCs have been appropriately
spiked in at a fixed quantity for each cell, so that the ERCC “expression” is absolutely stable across
cells. While technical factors may impede this assumption, the ERCCs provide the best option for
a known absolutely stable quantity.
More specifically, for each of the six Fluidigm C1 datasets we perform the following analysis.
We begin with raw counts of UMIs. We transform the raw counts by log + 1. In addition, for each
cell we also compute the sum of the raw UMIs of all ERCCs; we refer to this as the “ERCC total.”
Finally, for each gene, we compute Pearson’s correlation (across all cells) between that gene’s (log
+ 1) expression and the log of the ERCC total.
Ordinarily, one would expect the “ERCC total” Yi,ERCC to be approximately stable across all
cells, because the ERCCs are spiked-in at a constant level (i.e., Ei,ERCC is approximately constant).
Thus, the variability among the ERCC measurements should ideally be small, rendering the gene-
ERCC total correlations difficult to interpret. Indeed, this would be the case if we were using the
true ERCC totals Ei,ERCC rather than the measured ERCC totals Yi,ERCC. However, since the ERCC
measurements are subjected to the experiment and its corresponding technical biases (e.g., u in
Model 2.1), there is additional variability introduced to the ERCC totals. In fact, it appears that
the factors captured by u are quite large. The correlation between a gene and the ERCC total is
approximately the correlation between log(ui) + log(Ei,ERCC) and log(ti) + log(eij), ignoring wij
and the Poisson variability in Model 2.1 and assuming the +1 transformation is negligible. There-
fore, high correlations with the ERCC totals indicate that a given gene appears to be absolutely
stably expressed assuming t and u are correlated. In contrast, a low correlation with the ERCC
totals indicate that a given gene is not absolutely stably expressed or t and u are uncorrelated.
We then summarize the correlations by finding, for each gene, the mean of the correlations
across the six datasets. Thus, for each gene, we now have an average correlation of that gene’s
expression with the ERCC total, and we regard this as a measure of that gene’s absolute stability.
To see if any cellular structures are enriched for stably expressed genes, we plot histograms of the
correlations subsetted by structure, and inspect these histograms to see if the gene sets from any
structures have especially high correlations.
2.4.5 Proportional Stability
We also attempt to find genes that are proportionally stable. Our method is similar to the one for
absolute stability, but we replace the ERCC total with a total of endogenous genes. For a given
structure S, we sum a cell’s overall raw measured expression after removing the set of all genes
associated with structure S; we refer to this as an “adjusted cell total”. For each gene, we compute
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Figure 2.2: Histogram of the correlations of all genes with the ERCC totals. Figures 6.1 and 6.2
contain detailed histograms with separation based on the structure.
Pearson’s correlation (across all cells) between that gene’s (log + 1) expression and the log of the
adjusted cell total.
Again, we summarize correlations by finding, for each gene, the mean of the correlations across
the six datasets. For each structure, we plot a histogram of that structure’s correlations with that
structure’s adjusted cell total.
The log-transformed cell total according to Model 2.1 is approximately log(ti) + log(Ei,endo).
Individual genes (with expected measured expression on the log scale of approximately log(ti) +
log(eij), as modeled by Model 2.1) with high correlations with the cell total indicate that the gene’s
measurements appear to be proportional to the measured cell total, ignoring Poisson variability.
Conversely, genes with small gene-cell total correlations indicate poor proportional stability.
2.5 Results
2.5.1 Absolute Stability
Figure 2.2 shows a histogram of the correlations with the ERCC total; histograms of correlations
separated by gene sets can be found in Figures 6.1 and 6.2. The most notable observation is that all
correlations are smaller in absolute value than 0.3. One possible explanation for the weak corre-
lations is that no gene is absolutely stable. However, an alternative explanation is that the ERCCs
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and endogenous genes are affected by different technical artifacts, and we suspect in particular
that the spike-ins are not exposed to some strong technical effect(s) that do affect the endogenous
genes. In other words, it appears that the t and u from Model 2.1 are quite different, likely from the
different capture and reverse transcription efficiency as described by Vallejos et al. [2017]. Figure
2.4 shows that, on the log scale, the endogenous cell totals and ERCC totals (Yi,endo and Yi,ERCC,
respectively) have a low correlation, further indicating that t and u are indeed different. As cells
need to be lysed and RNA needs to be extracted from the cells, we believe that this may introduce
technical factors which affect the measurements of endogenous genes while the spike-ins do not
experience the same variability.
Supporting these claims, the spike-ins exhibit much lower variability than the endogenous
genes within our datasets. We compare the ERCC cell total to the endogenous cell total on a
log scale for each of the datasets (Figure 2.3). From Model 2.1, this approximately corresponds
to comparing log(ui) + log(Ei,ERCC) and log(ti) + log(Ei,endo), respectively. If we suppose that
the spike-ins are appropriately added to the experiment, then Ei,ERCC should be stable. Similarly,
since all of our cells are of the same type, it is reasonable to assume that Ei,endo could be relatively
constant. Following from these assumptions, Figure 2.3 allows us to compare the variability in
ui to ti. We see that the variability for the ERCC measurements is considerably smaller than the
variability for the endogenous gene measurements, sometimes by orders of magnitude.
Figure 2.4 displays the logged totals of the endogenous genes and the ERCC spike-ins. Fol-
lowing the modeling assumptions discussed above, the scatterplots allow us to estimate the size
of technical effects unique to ti and ui relative to any shared technical effects, like amplification
and sequencing biases. If the shared technical effects contained within ti and ui were much larger
than those unique to the endogenous genes or spike-ins, then the scatterplots would have strong,
linear relationships. However, the scatterplots show poor correlations, indicating that the technical
factors affecting the endogenous genes and spike-ins separately dominate the cell scaling factors.
The variability of the ERCC measurements appear to capture different technical effects than those
that affect the endogenous genes. Figure 2.5, which examines the mean and standard deviation of
each of the endogenous genes and ERCC spike-ins separately, demonstrates that, again, the ERCC
spike-ins have much lower variability when compared to endogenous genes with similar overall
expression.
For each gene set, we plot the mean correlation with the total ERCC spike-ins from a dataset
in Figure 2.6. One feature to note is that the mean correlation for GSE84686 is negative for each
of the gene sets and appears substantially smaller than other five. This negative relationship is
driven by an overall correlation of -0.28 between the log of the total UMIs and the log of the total
ERCC spike-ins (Figure 2.4). We suspect that this relationship exists as a result of the ERCC mea-
surements overpowering the transcripts for a given cell, especially with the high levels of ERCCs,
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Figure 2.3: Boxplots of the ERCC and endogenous gene totals from each cell. The blue boxplots
are of the log (base 2) transformed sum of the endogenous expression for each cell, while the
orange boxplots are of the log-transformed sum of the ERCC measurements. Note that the range
of endogenous totals is often several units on the log scale, indicating variability that spans orders
of magnitude. Specifically, for a cell total at 215, the associated standard deviation from Poisson
sampling would extend only 0.008 on the log-scale. The expected variation from the Poisson
sampling is dwarfed by the overall variability of the cell totals. Note also that GSE84686 is an
outlier in many respects.
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Figure 2.4: Scatterplots of the endogenous gene and ERCC totals, on the log (base 2) scale, from
each cell. Note that GSE84686 has a negative correlation. Note also that the ERCC measurements
from GSE77288 vary, consistent with the original publication that an experimental error occurred
[Tung et al., 2017].
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Figure 2.5: Scatterplots of the mean and standard deviation of ERCC spike-ins and the endogenous
genes on the log scale for each of the six datasets. From these graphs, it appears that the variance
exhibited by the spike-ins is smaller than those for endogenous genes, after accounting for the
mean measured expression.
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as seen in Figure 2.3. We see that highly expressed sets of genes, including the cytosolic riboso-
mal and ribosomal genes, have the lowest mean correlations in GSE84686, further supporting this
hypothesis.
Overall, the spike-ins appear to have measurements that are far more stable than the endogenous
genes. Since each dataset captures one type of cell, and because the range of endogenous cell totals
is so large (orders of magnitude), we suspect that technical effects likely contribute to much if not
most of the variation observed in the endogenous totals. Moreover, the technical factors affecting
the endogenous cell totals appear stronger than technical factors affecting the spike-ins, suggesting
in particular that the spike-ins may not be capturing the same technical effects. If so, using spike-
ins to identify genes that are absolutely stably expressed is inappropriate.
Model 2.1 further supports the interpretation that the technical factors that affect the ERCC
spike-ins are different than those that affect the endogenous genes. Specifically, there are some
experimental processes that differ for spike-ins. Spike-ins are incorporated into the experiment in
a different manner and sometimes at a different time point than endogenous genes, which intro-
duces experimental inconsistencies in protocols, like being pipetted in at a specific volume and not
being lysed from a cell. Additionally, the spike-ins have synthetic characteristics, including their
manufactured nature and their varying properties designed to capture technical effects. Finally,
the amounts with which the spike-ins are introduced into the experiment differ. The spike-ins are
often incorporated at an amount inconsistent with the expression level of the endogenous genes.
Any factors affected by overall expression level would disproportionately affect the spike-ins. The
differences between the spike-ins and the endogenous genes are represented by t and u in Model
2.1 and appear to be different from the data. The endogenous technical effects may not be captured
well by the spike-ins. Therefore, spike-ins are unlikely to be helpful for removing the technical
effects from the endogenous measurements.
2.5.2 Proportional Stability
We examine the measures of proportional stability in Figures 2.7, 6.3, and 6.4. Unlike the correla-
tions with the ERCC measurements, we see large correlations, with values ranging from -0.03 to
0.95. The cytosolic ribosomal genes appear especially enriched in proportionally stable genes.
We plot the mean correlation of each gene set with the unadjusted cell total by dataset (Figure
2.8). The spread and the ordering of the datasets are similar for each structure. Thus, it appears
that mean correlations are an appropriate summary for a gene’s correlation across the six datasets.
Cytosolic ribosomal genes are typically highly expressed. We create a set of highly expressed
single cell genes to assess how high expression affects stability. We find the top 100 highly ex-
pressed genes in each of the six Fluidigm C1 datasets. The union of these six lists produces a
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Figure 2.6: For each set of genes, we calculate the mean correlation with the ERCC total, on the
log scale. The mean correlations are shown here for each of the six Fluidigm C1 datasets. These
correlations exhibit a clear pattern based on dataset, indicating variation by dataset in the measures
of absolute stability. The patterns of the distribution are similar across the structures, indicating
that the average correlations is an appropriate summary of the six datasets.
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Figure 2.7: Histograms of the average correlations of each gene over the six Fluidigm C1 datasets
considered, with comparisons between the set of genes of interest (red) and the remaining genes
(green). Only some of the structures are shown here; the remaining structures can be found in
Figures 6.3 and 6.4. The highly expressed genes (bottom right panel) consist of the union of the
top 100 genes by average expression, excluding the cytosolic ribosomal genes. The correlations
plotted here are averages across the six Fluidigm C1 datasets, but no single dataset seems to be
contributing to the averages differently across the gene sets; see Figure 2.8.
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Figure 2.8: For each set of genes, we calculate the mean correlation with the unadjusted cell total.
These mean correlations are shown here for each of the six Fluidigm C1 datasets. The patterns
of the distribution are similar across the structures, indicating that the average correlations is an
appropriate summary of the six datasets.
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Table 2.4: Distribution of Cell Structures Amongst Highly Expressed Genes
Structure All Genes Highly Expressed
Number of Genes 8,605 157
Nucleus (4,280) 50% 66%
Endoplasmic Reticulum (934) 11% 11%
Golgi Bodies (850) 10% 5%
Cytoplasm (2,600) 30% 39%
Ribosome (177) 2% 0%
Mitochondria (1,187) 14% 27%
Mitochondrial Ribosome (75) 1% 0%
Ribonucleoprotein (185) 2% 9%
Membrane (3,160) 37% 43%
Cytosolic Ribosome (103) 1% 0%
Eisenberg & Levanon (470) 5% 34%
Lin et al. (967) 11% 20%
This table is essentially an extension of Table 2.1 to include the highly expressed single cell genes.
set of 231 genes. We remove the cytosolic ribosomal genes from this set, resulting in 157 highly
expressed genes. The structure associations of the highly expressed single cell genes are shown
in Table 2.4. We then perform the same correlation analysis as for the other gene sets, seen in
the bottom-right panel of Figure 2.7. We can see that the cytosolic ribosomal genes are especially
stable even relative to this set of other highly expressed genes.
Cytosolic ribosomal genes also have a low proportion of zero counts, but this does not seem to
be driving the high correlations. We recomputed the correlation histograms after removing cells
with zero counts for a given gene (Figures 2.9 and 6.5). Comparing these to Figures 6.3 and 6.4, we
see a similar pattern in the correlations with the cytosolic ribosomal genes exhibiting the highest
measures of proportional stability.
Ribosomal genes, from which the cytosolic ribosomal genes are a subset, have been previously
identified as relatively stable. Thorrez et al. [2008] found that ribosomal genes were the most
stable set of genes that they had encountered in microarray experiments, but Thorrez et al. [2008]
also note that the ribosomal genes do exhibit tissue-dependent variation.
We compare the correlations of cytosolic ribosomal genes to those of GAPDH and Beta-actin,
two genes that have previously been identified as stable genes. Both GAPDH and Beta-actin appear
to have similar or smaller correlations as the cytosolic ribosomal genes (on average), indicating that
the proportional stability is similar to two commonly used stable genes; the correlation for GAPDH
is 0.82 and for Beta-actin is 0.75. For a comparison of correlations between these two genes and
the cytosolic ribosomal genes, see Figure 2.10.
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Figure 2.9: Histograms of the average correlations of each gene over the six Fluidigm C1 datasets
considered, with comparisons between the set of genes of interest and the remaining genes. Cells
with zero counts for individual genes were removed before calculating the correlations with the
adjusted cell total. Continued in Figure 6.5.
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Figure 2.10: The average correlations of Beta-actin (ACTB) and GAPDH with the cell total over
the six datasets. Note that, unlike Figure 2.7, the correlations here are with the unadjusted cell
total rather than an adjusted cell total. This allows correlations between ACTB, GAPDH, and the
cytosolic ribosomal genes to be comparable.
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In addition to their high measures of proportional stability, we again note that the cytosolic
ribosomal genes are highly expressed (Figure 2.11) and have a low proportion of zero counts
(Figure 2.1), which further suggests they may be effective as reference genes.
2.5.3 Stability of Cytosolic Ribosomal Genes in the 10x Platform
2.5.3.1 Proportional Stability
We further evaluate the cytosolic ribosomal genes for proportional stability in datasets generated
with the 10x platform [Zheng et al., 2017], assessing the robustness of our results from the Flu-
idigm C1 platform. Using the same measures from the Fluidigm C1 data, the cytosolic ribosomal
genes again appear to be enriched in proportionally stable genes, extending our findings of propor-
tional stability to another platform (Figures 2.12 and 6.6).
Note that we mentioned that some characteristics of GSE84686 are unusual, including the mea-
sured ERCC spike-ins and the small correlations calculated with both the ERCC spike-ins and the
biological cell totals. Both Jurkat cells and GSE84686 contain T cells. The size of the correlations
obtained from the Jurkat cells are similar to those found in other datasets. In addition, measures
of proportional stability for GSE84686 from the cytosolic ribosomal genes are higher than those
measures for other gene sets. Together, these two facts suggest that the cytosolic ribosomal genes
are proportionally stable, and that the size of the proportional stability measure for GSE84686 is
likely influenced by other aspects of the data than by a lack of proportional stability of the cytosolic
ribosomal genes.
2.5.3.2 Stability Across Species
The proportional stability of the cytosolic ribosomal genes seems to be robust based on species.
We examine the additional 10x dataset that contains a mixture of human and mouse cells, 293T
and 3T3 cells respectively. We did not create a full structural annotation dictionary for mouse
genes as we did for human. Rather, we approximate the set of cytosolic ribosomal genes with
those genes that begin with a prefix of either ‘RPS’ or ‘RPL’ in humans or with a prefix of ‘Rps’
or ‘Rpl’ in mice. We selected these genes based on the patterns observed in Section 6.2.2. Using
this approximation, we capture 82 of 108 cytosolic ribosomal genes in the human 293T dataset
and include an additional 15 genes that are not cytosolic ribosomal genes.
Using the approximated set of cytosolic ribosomal genes, we calculate the proportional sta-
bility measures with the correlation between genes and the adjusted cell total after removing the
approximated set of cytosolic ribosomal genes. We repeat the same procedure for the 3T3 mice
dataset. Figure 2.13 indicates that the proportional stability of cytosolic ribosomal genes, based on
our approximated set of genes, appears similar in mice and humans.
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Figure 2.11: Summary characteristics of the expression of cytosolic ribosomal genes across cells
and across datasets. The boxplot on the top shows all of the expression measurements by dataset
for the cytosolic ribosomal genes, transformed with the log + 1. For comparison, the proportion of
zeros in each of these datasets is 80%, 41%, 42%, 63%, 76%, and 82%, respectively and means (on
the log + 1 scale) of 1.23, 1.26, 1.37, 0.71, 0.45, and 0.30, respectively. The boxplot on the bottom
looks at the expression (log + 1) of each of the cytosolic ribosomal genes within GSE89235.
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Figure 2.12: Histograms of the average correlations of each gene with the adjusted cell total over
the four human 10x datasets, with comparisons between the gene sets of interest and the remain-
ing genes. This figure is continued with Figure 6.6 with histograms for the other six gene sets
considered.
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Figure 2.13: Comparison of correlation histograms of estimated cytosolic ribosomal genes in hu-
man and mouse. We approximated cytosolic ribosomal genes with those genes that contained a
prefix of Rps or Rpl (for mouse cells) and RPS or RPL (for human cells). Based on the human
gene information, these genes capture the set of cytosolic ribosomal genes fairly well.
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Figure 2.14: Singular Value Decomposition of GTEx data from the brain using different sets of
genes. The overlap of the clusters denoted by the coloring indicate how stably expressed the genes
are; the overlap is the strongest for the cytosolic ribosomal genes, indicating that they are the most
stably expressed of the three options between the brain subtissue types. Note that the number of
genes in each of the four SVD plots differ. More specifically, 89 cytosolic ribosomal genes are
present in the available GTEx data, while more of the other three gene sets are present. To ensure
that differences in the number of features are not accounting for differences in apparent differential
expression, we repeat the analysis with random samples of 89 genes from each of the gene sets
with similar results.
2.5.4 Stability of Cytosolic Ribosomal Genes in Bulk Tissues
To assess the stability of cytosolic ribosomal genes in bulk samples from many tissue types, we
analyze data collected with bulk sequencing from the Genotype-Tissue Expression (GTEx) project
[Carithers et al., 2015]. The GTEx project systematically collects multiple tissue types from many
individuals for genetic profiling and analysis. The tissue types are often subcategorized into addi-
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Figure 2.15: Singular Value Decomposition of GTEx data from the brain using the top 100 highly
expressed GTEx genes and the cytosolic ribosomal genes. This figure extends the analysis in
Figure 2.14 to incorporate the set of highly expressed genes.
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Figure 2.16: Histograms of the IQRs of cytosolic ribosomal genes and the top 100 highly expressed
genes from the brain, with small IQRs indicating stable expression. Figures 6.11 to 6.17 show
similar figures for additional tissue types and comparison gene sets.
tional subtissue types.
We examine the stability of different sets of genes by seeing how strongly their expressions
vary across tissue type. More specifically, for a given set of genes, we compute the singular-
value decomposition (SVD) and plot the first two singular vectors to see how strongly the samples
cluster by tissue type. Prior to calculating the SVD, the GTEx samples are RPKM-normalized,
transformed with log + 1, and centered by gene. In these plots, clustering by tissue type indicates
that the genes examined have some differential expression between tissue types, whereas lack of
clustering provides evidence of stable expression across tissue types. We examine the SVD plots
to assess the stability of the cytosolic ribosomal genes compared to other sets of genes.
We perform the SVDs for both single tissues and combinations of two tissue types. We select
the seven tissue types with the most samples (brain, skin, esophagus, blood vessel, adipose tissue,
heart, and muscle); of these, six have subtissue types. We first plot the SVD for these six tissue
types separately with coloring by subtissue type to examine how stably expressed genes are within
a tissue type (Figure 2.14). We extend Figure 2.14 in Figure 2.15 by generating an SVD plot
comparing the stability of the cytosolic ribosomal genes to highly expressed genes from the GTEx
data. Our set of 100 highly expressed genes in the GTEx data are generated by calculating the
top 151 genes according to their average expression of RPKM-normalized and log-transformed
GTEx measurements and removing the 51 cytosolic genes within this set. The cytosolic ribosomal
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Figure 2.17: Singular Value Decompositions of GTEx data from the esophagus and blood vessel
and blood vessel and heart, using different sets of genes as features. For each set of tissues, the
first plot on the top left uses all genes as features; the plot on the top right uses genes proposed
by Eisenberg and Levanon [2003] as features; the plot on the bottom left uses genes proposed
by Lin et al. [2019a] as features; and the plot on the bottom right uses cytosolic ribosomal genes
as features. The two tissue types are denoted by either the circle or cross symbol, and the tissue
subtypes are denoted by the coloring. The esophagus and blood vessel overlap substantially for the
cytosolic ribosomal genes, indicating that their expression is reasonably stable across these tissues
and subtissues. Overlap is much smaller for the other three sets of genes, indicating less stable
expression of these gene sets. The separation for the blood vessel and heart is clear, indicating that
the four sets of genes are not stably expressed across the blood vessel and heart; this separation is
one of the strongest that we observed. We performed SVDs for random samples of 89 genes from
each gene set with similar results, indicating that the size of the gene set is not driving the results.
genes appear more stably expressed both within and across tissue types compared to the highly
expressed GTEx genes. Thus, it appears that the high expression of cytosolic ribosomal genes is
not driving their apparent stability, further supporting the results from the scRNA-seq data. Figure
2.16 assesses the stability of the cytosolic ribosomal genes, comparing their IQRs to those of the
GTEx highly expressed genes.
We also plotted SVDs for each combination of two of the seven tissue types to examine how
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stably expressed genes are across those two tissue types. Figure 2.17 shows two sets of two tissue
types across which the cytosolic ribosomal genes are especially stable (left panel) and especially
not stable (right panel). In general, the cytosolic ribosomal genes exhibit the most stable expression
of the gene sets examined between subtissue types and across different tissue types. However, as
also noted by Thorrez et al. [2008], the cytosolic ribosomal genes are not highly stable across all
tissue types.
2.6 Table of Gene Information
On the whole, the cytosolic ribosomal genes appear to be relatively stable. However, they are
not uniformly stable across all tissue types. Thus, although the cytosolic ribosomal genes may be
a good starting point for a set of reference genes, in most cases a researcher may want to further
refine this set. We have therefore generated a database that contains summary information about the
genes in our Fluidigm C1 and GTEx datasets. This database contains our structural annotations;
means, standard deviations, and correlations from the single cell datasets; and means, standard
deviations, and F-statistics for the tissue types from the GTEx data. This information can be used
to identify and exclude genes that are not especially stable or reliably detectable in a given tissue
type, or to allow a researcher to impose more stringent stability requirements, or to discover other
gene sets that may be suitable for a given application. Detailed information about the database can
be found in Section 6.6, and the database can be accessed through GitHub (johanngb/sc-stable).
2.7 Discussion and Conclusions
We have found that cytosolic ribosomal genes, as a whole, appear to be relatively stably expressed
in proportion to the total RNA content of a cell. Our findings are robust across many single-cell
datasets, including those generated with both Fluidigm C1 and 10x platforms. Expression patterns
of cytosolic ribosomal genes observed in bulk GTEx experiments further support the conclusion
that cytosolic ribosomal genes are relatively stably expressed.
Our focus in this chapter has been limited to identifying sets of stable genes, and we have not
yet discussed specifically how such genes might ultimately be used to perform a normalization. A
full discussion is beyond the scope of this chapter, but we highlight here some key points. One of
the primary challenges is that the cytosolic ribosomal genes, while on the whole relatively stable,
are not perfectly so. This can be seen in Figure 2.7, where the histogram for the cytosolic ribosomal
genes has a long left tail, suggesting that at least some of these genes are not particularly stable.
It can also be seen in Figure 2.16, where we see that a small number of cytosolic ribosomal genes
have large IQRs, and in Figure 2.17, where we see evidence of differential expression between
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blood vessel and heart. Similar findings have been reported elsewhere in the literature [Islam
et al., 2011; Ilicic et al., 2016; Thorrez et al., 2008]. Indeed, our findings are similar to those of
Thorrez et al. [2008], who reported that ribosomal genes were the most stable set of genes that
they had encountered, but still do exhibit tissue-level dependence.
Nonetheless, we believe that even genes that are only approximately stable may still be po-
tentially useful for normalization. For example, GAPDH and Beta-actin are routinely used for
normalization in many contexts, despite the fact that these genes may also exhibit some degree of
tissue-level dependence [Oyolu et al., 2012; Barber et al., 2005; De Jonge et al., 2007; Islam et al.,
2011]. Indeed, we have found the stability of cytosolic ribosomal genes to be comparable to that
of GAPDH and Beta-actin (Figure 2.10).
We see two main approaches to ensure a normalization based on cytosolic ribosomal genes is
effective, given the imperfect stability of this set of genes. The first is methodological. Recent
methods have been developed that exploit a set of reference genes to perform a normalization, but
that are also reasonably robust to at least some instability within the reference set [Wang et al.,
2017; Gagnon-Bartsch et al., 2013]. That is, these methods may still be effective even when the
reference gene set is only approximately stable. In particular, the method of Wang et al. [2017]
requires that only 50% of the designated reference genes actually be stable.
The second approach is to refine the set of reference genes for any given application, to ensure
that the chosen set is as stable as possible. For this, we have created the table of gene information
described in Section 2.6. In addition to the structural annotations, the table contains summary
statistics from our analyses that allow one to quickly identify genes that are not stable in any of the
single cell datasets or in a given tissue type (using GTEx data). For example, using this table, one
can easily identify the genes in the long left tail of the histogram of correlations in Figure 2.7, or
the genes in the long right tail of Figure 2.16, and remove them from consideration.
We have emphasized in this chapter that the notion of stability at the single cell level is am-
biguous. We attempt to clarify specific notions of stability, and in particular consider absolute and
proportional stability. We argue that the distinction is important, as the notion of stability implic-
itly defines the notion of variability (or differential expression, etc.), with implications for not just
“data cleaning,” but also biological interpretation.
While we were able to identify cytosolic ribosomal genes as proportionally stable, our attempts
to identify absolutely stable genes were not successful. We attempted to leverage the (presumed)
absolute stability of ERCC spike-ins to identify endogenous absolutely stable genes. However, we
concluded this approach is infeasible because of strong technical factors that affect the endogenous
genes, but not the spike-ins, rendering correlations between the two effectively meaningless. We
proposed a model (Model 2.1) for the expression measurement that incorporates the technical
effects that we suspect to help motivate future work. Nonetheless, our hope is that our work has
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highlighted both the challenges and the importance of identifying such a set of genes and will
encourage future work in that direction.
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Chapter 3
Modeling Biases of Reads per UMI in Single-Cell
RNA-Sequencing
3.1 Abstract
Single-cell RNA-sequencing (scRNA-seq) experiments measure the RNA transcripts present in a
single cell but are subject to many technical effects. Both experimental and analytical approaches
have been proposed to adjust for technical effects and reduce biases in scRNA-seq data, including
unique molecular identifiers (UMIs) and normalization procedures. We propose a measure of
technical effects captured through the experiment, reads per UMI (rUMI). We further propose an
estimator of the mean rUMI. We aim to estimate the unobserved proportion of molecules lost due
to technical effects, i.e. 0 rUMI, by extrapolation. The estimated proportion of 0 rUMI can then
serve as a measure of technical loss in an experiment. We observe the relationship of various
transcript characteristics with rUMI based on a scRNA-seq dataset. Further, we generate a model
to estimate rUMI based on biological characteristics of a gene and UMI. We discuss how patterns
observed in our analysis can be incorporated into downstream normalization procedures, reducing
some of the biases introduced from technical artifacts.
3.2 Introduction
Single-cell RNA-sequencing (scRNA-seq) provides the ability to record gene expression at the
cellular level. This detailed level of measurement allows for finer understanding of a given tissue
or sample. However, measurements are susceptible to a large number of technical effects. Some
sources of technical effects, like amplification biases and sequencing errors, have well documented
and understood effects [Dabney and Meyer, 2012; Benjamini and Speed, 2012; Aird et al., 2011];
specifically, an imbalance of guanine and cytosine (GC) bases relative to adenine and thymine
(AT) bases in a transcript results in inferior amplification. Other sources, like the introduction of
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ambient mRNA or cell stress and death, have been proposed as sources of unwanted variation but
are less understood [Bacher and Kendziorski, 2016; Stegle et al., 2015].
Experimental and analytical methods designed to distinguish technical effects from biological
ones have been proposed. Specifically, Unique Molecular Identifiers (UMIs) provide a barcode to
tag a transcript captured from a cell. UMIs mark duplicated reads from the same transcript result-
ing from amplification, preventing artificial inflation of measured gene expression. In particular,
UMIs reduce biases associated with transcript length and composition of GC bases in the transcript
[Phipson et al., 2017; Kivioja et al., 2012; Islam et al., 2014]. Analytically, Buettner et al. [2015]
propose a method to identify genes that distinguish technical from biological variability. Chen and
Zhou [2016] adjust for confounding effects, relying on the assumption of a linear model with single
cell Partial Least Squares (scPLS). Methods to remove technical effects in other gene expression
experiments include those proposed by Irizarry et al. [2003] for microarrays, Love et al. [2016] for
bulk RNA-seq, and Risso et al. [2014] also for bulk RNA-seq.
One prominent feature in scRNA-seq data is a high proportion of zero counts, or dropouts. Zero
counts occur when no transcripts are aligned to a given gene within a cell, resulting in a zero entry
in the gene × cell digital gene expression matrix. Often, the proportion of zero counts is close to
90% [Bacher and Kendziorski, 2016; Grün et al., 2014; Kim et al., 2015; Dijk et al., 2017]. The
zero counts may be biologically accurate or a result of technical effects. Hicks et al. [2015] suspect
that lowly expressed genes experience a larger proportion of zero counts, rather than zero counts
occurring randomly, due to stronger technical variations that affect their measurements. Analytical
approaches to account for the high proportion of zero counts include zero-inflated models proposed
by Pierson and Yau [2015] and Risso et al. [2017].
In addition to the zero counts, experimental results indicate that scRNA-seq does not capture
a complete representation of the tissue. Thus, in addition to high zero counts, the available data
only provide a general measurement of the gene expression at the cellular level, suggesting addi-
tional normalization or analytical steps to refine the data. It is estimated that between 5 − 40%
of transcripts from a given cell are captured [Stegle et al., 2015; Kolodziejczyk et al., 2015]. Ad-
ditionally, 10 − 60% of cells are expected to be captured in droplet-based scRNA-seq protocols
[Macosko et al., 2015]. We then expect less than 25% of the transcripts in a sample to be captured
in a droplet-based scRNA-seq dataset. For well-based scRNA-seq protocols, the number of cells
captured are limited to the number of wells available; well-based protocols often capture fewer
cells than droplet-based ones.
To assess batch effects in scRNA-seq, Tung et al. [2017] measured the conversion of reads
to molecules based on UMIs at the cellular level, finding both biological and technical variation
affecting the conversion. Thus, Tung et al. [2017] conclude that UMIs do not provide an unbiased
estimate of gene expression. Specifically, Tung et al. [2017] perform scRNA-seq experiments to
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measure both intra- and inter-individual differences by using multiple Fluidigm C1 plates for one
individual. Technical effects are observed through different read to molecule conversion ratios
across plates from the same individual, while biological effects are additionally present across
individuals. We propose exploring a similar measure as Tung et al. [2017] at the transcript level,
endeavoring to capture technical effects.
Our goals for this Chapter are: (1) to motivate a transcript-level reads per UMI measure as
a way to capture technical effects, (2) to propose a robust estimator for a zero-truncated Poisson
parameter, and (3) to summarize the relationship between biological characteristics of interest and
rUMI, indicating what factors may be related to reliable detection of genes.
3.3 Methods
3.3.1 Reads per Unique Molecular Identifier
We calculate the number of reads per UMI (rUMI) as an approach to help understand some of the
technical biases from the experiment. Typically, multiple reads associated with the same UMI are
deduplicated before being summarized in the cell × gene expression matrix, partially removing
amplification and sequencing biases. Information contained in duplicated reads from the same
UMI may provide additional insights into the technical effects associated with the experiment. We
anticipate that rUMI captures some of the technical biases present during both amplification, when
multiple transcript copies are generated for a UMI, and sequencing, converting the transcripts into
reads outputted by a sequencer. The rUMI measure summarizes technical effects at the transcript
level, thereby capturing effects introduced by transcript and UMI characteristics, including the
proportion of GC and length of a transcript. Compared to the cell-level conversion ratio of Tung
et al. [2017], we can observe gene-level and UMI-level biases present using rUMI. Therefore, we
measure the rUMI by counting the number of reads obtained after sequencing that are associated
with that UMI; in essence, we enumerate the amount of deduplication that occurs as a result of the
experimental inclusion of UMIs. Note that 0 rUMIs cannot be recorded.
While UMIs are intended to be unique, they are not perfectly unique. The length of the molec-
ular barcode component of the UMI is often 8 base pairs; see Section 7.1.5 for more details. This
provides 65,536 options for the molecular barcode; there is no way to ensure that every possible
molecular barcode is used, or that there will be fewer than 65,536 transcripts captured in a given
cell. Thus, some UMIs are repeated. We therefore consider the aligned gene as a secondary fac-
tor for distinguishing UMIs, with this characteristic helping to capture multiple transcripts being
assigned to the same UMI. We discuss in Section 3.4.1 the plausibility of the UMI and gene fully
distinguishing transcripts.
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Zero counts are distinct from 0 rUMIs, although there is a connection between these situations.
Specifically, zero counts can occur through one of three mechanisms. First, a gene may not be
expressed in a given cell, resulting in a zero count for that given gene. Second, a gene may be
expressed without any of its transcripts binding to a UMI. Thus, the transcripts are present but
are never assigned a UMI. Finally, a gene may be expressed with at least one transcript assigned
to a UMI. Every transcript assigned to a UMI for that gene must have 0 rUMI to result in a zero
count in the gene expression matrix. Thus, a zero count indicates that any transcripts must have 0
rUMI, but 0 rUMI for a transcript does not ensure a zero count. While the rUMI estimator cannot
distinguish between zeroes introduced from these three situations, it can estimate how often we
expect 0 rUMI to occur.
3.3.2 Experimental Data
We obtained datasets generated and processed by the Hammoud lab at the University of Michigan
[Green et al., 2018]. Sertoli cells involved in spermatogenesis were isolated with an in-house
drop-seq protocol (droplet-based cell isolation). UMIs were incorporated into the protocol, and the
library was sequenced using an Illumina platform. Pre-processing steps were performed according
to the pipeline published by the McCarroll Lab [Nemesh, 2015]. The typical pipeline was exited
prior to the creation of the digital gene expression matrix and adjusted after alignment to record
features about the barcodes, transcripts, and genes.
After filtering according to the standards set by Nemesh [2015], the gene expression for 1,521
cells was recorded for 17,237 genes (11,825,578 UMIs and 91.16% zeros). The 100 cells with the
highest number of UMIs contribute 26.02% of the UMIs while comprising 6.57% of the cells in
the sample (73.44% zeros across 15,215 genes). We filtered to the top 10 cells with the highest
number of UMIs, resulting in 302,054 reads from 244,272 UMIs with an average of 1.24 rUMI
(sd=0.54); note again that we can not record 0 rUMI. We consider 20 additional cells in Section
7.2.
3.3.3 Estimation of rUMI
Biologically, a zero-truncated Poisson distribution, that is a Poisson distribution modified so that
P(X = 0) = 0, is a reasonable model for the distribution of rUMIs; the probability mass function
is shown in Equation 3.1. Other distributional choices are analytically and biologically plausible,
but the Poisson model is often proposed by biologists [Robinson and Oshlack, 2010]. We discuss
additional distributions and estimators resulting from these distributions in Chapter 4.
39
Figure 3.1: A comparison of the estimated distribution using λ̂ from Equation 3.2 with the distri-
bution of rUMI to be modeled.
P(X = x) =
e−λλx
x!(1− e−λ)
; x = 1, 2, . . . ,∞. (3.1)






When applied to the 244,272 UMIs from the 10 largest cells, λ̂ = 0.38. Figure 3.1 shows the
estimated zero-truncated Poisson distributions based on the estimated λ̂.




















Further details can be found in Section 4.4.2.2.
We can further apply our estimator to subsets of the data. For example, we can estimate λ̂ for
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some group of the data i as
λ̂,i = 2
∑
s∈Si I(rUMIs = 2)∑
s∈Si I(rUMIs = 1)
, (3.4)
where Si represents the members of group i. We create categorical groupings of our variable of
interest to form Si used in estimating λ̂,i. Redefining our variable in terms of groups provides flex-
ibility for the form of the relationship between the variable of interest and rUMI without imposing
any restrictions on the relationship. For quantitative variables, we use intervals that form (roughly)
equally sized groups.
From the estimated λ̂ values, we can also estimate the probability of the technical loss of
a transcript based on the Poisson distribution, i.e. P(rUMI = 0) = e−λ̂. We are particularly




We consider the total number and standard deviation of UMIs recorded for each gene and for each
cell in the 1,521 cells and 17,237 genes in Figure 3.2. Low measured expression is apparent for
many of the cells and genes from Figure 3.2, with some genes and some cells accounting for a
large proportion of the measured UMIs.
After filtering to the top 100 cells, we see that the relationship between the number of reads
and number of UMIs appear fairly linear in Figure 3.3. There are some cells that experience higher
overall rUMI than the general pattern. There is some variation of rUMI for genes but no obvious
genes appear to be outliers from the right panel of Figure 3.3.
We perform our analyses for the top 10 cells based on total number of UMIs. Section 7.2
provides a similar analysis for 20 additional cells. Figure 3.4 displays the distribution of rUMI
for the 244,272 UMIs. More than 80% of the UMIs are captured from a single read. Further
evidence of shallow sequencing comes from λ̂ evaluated on the full sample, which indicates that
the probability of having 0 rUMI is 68.36%, or that more than 2 of every 3 transcripts that are
assigned a UMI, i.e. bind to a bead, will not be included in the final set of reads.
As mentioned in Section 3.3.1, we applied the gene in addition to the UMI in identifying
distinct transcripts. We suspect, however, that the long right tail in Figure 3.4 may be an artifact of
UMIs not being perfectly unique. Specifically, it is possible that the 9 rUMI value in fact represents
two (or more) distinct transcripts from the same gene that were assigned to identical UMIs. Thus,
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Figure 3.2: Scatterplots of the total number and standard deviation of UMIs from the full dataset of
17,237 genes (left panel) and 1,521 cells (right panel). A large proportion of genes and cells have
small overall expression levels. There is a clear dependence between the total number of UMIs
recorded and standard deviation.
Figure 3.3: The relationship between the total number of reads and the total number of UMIs for
the 100 cells with the highest number of UMIs. The left panel shows the relationship for the 100
cells, and the right panel shows the relationship for the genes.
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Figure 3.4: The distribution of rUMI for all transcripts and for full length transcripts from the top
10 cells. More than 80% of the UMIs were found in only 1 read, indicating shallow sequencing.
we consider the distribution of rUMIs without incorporating the gene as a distinguishing factor
in Figure 3.5. We see the rUMI values now extend to 19, and that the proportion of 1 rUMIs is
reduced to 62.6%. From this distribution, our overall estimates of λ̂ changes to 0.74 from 0.38.
Additionally, we explore characteristics of the 20 largest rUMIs (7-9 rUMI). First, we examine
the measured expression level of the genes associated with these 20 reads. 14 of the genes from
the top 20 rUMIs are in the top 10% of measured gene expression. Genes with large measured ex-
pressions indicate that the transcripts are more abundant within a cell, and thus are more likely to
have multiple transcripts assigned to identical UMIs. Additionally, we examine if molecular bar-
code characteristics might contribute to repeated UMIs, concluding that this is unlikely. Adding
the gene as a separating characteristic resulted in a 30% increase in the number of molecules
counted. Within the top 20 rUMIs, including the gene as a separating factor increased the num-
ber of molecules by 40%, a modest increase. While UMI characteristics could contribute to the
large number of rUMIs measured, one would expect most of the top molecular barcodes to have
multiple additional reads originating from each of the 10 cells. However, half of these molecular
barcodes had 5 or fewer additional copies, most of which originated from different cells. Neither




One of the first variables that we examine, transcript length, contains a high proportion of UMIs
at the maximum length of 151 base pairs (bp), as seen in Figure 3.6. The maximum length of 151
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Figure 3.5: The distribution of rUMI with and without using gene to distinguish between
molecules. UMIs with identical UMIs but distinct genes likely occur from different original
molecules, even though the UMIs are identical.
bp was selected prior to sequencing based on experimental protocol. Thus, we perform two sets
of analyses, one including all transcripts and another for full length transcripts, for the remaining
variables. First, we examine the distribution of rUMI for the full length reads in the bottom panel
of Figure 3.4, finding that an even larger proportion of UMIs are captured with only one rUMI than
from all reads.
We examine how length is related to rUMI in the right panel of Figure 3.6. We see the largest
estimate for mean rUMI occurs for the length interval that is not quite full length. We suspect that
UMIs with multiple reads may consist of one (or more) full length reads and one (or more) reads
that are close to full length. The average read length for the UMI would approach but not reach the
full 151 bp, increasing the estimate for λ̂,i for the UMIs with the second-longest average length.
3.4.2.2 Transcript Proportion of Guanine and Cytosine
We calculate the proportion of guanine and cytosine (GC content) for the full length of the tran-
script, for the first half of the transcript, and for the second half of the transcript. For UMIs with
multiple reads, we summarize these measures with the mean of the proportion GC content for each
read.
Figure 3.7 displays the estimates from Equation 3.2 for the average GC content of the full
transcript. An AT/GC imbalance results in smaller λ̂,i estimates, indicating that genes with an
imbalance of bases may result in lower rUMI. The full length reads, however, exhibit a less clear
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Figure 3.6: The average transcript length ranges from 13 to 151 bp, with almost half of the values
consisting of full length reads (left panel). The scatterplot on the right displays how the estimated
rUMI parameter is related to read length, with the largest estimate for reads that are close to but
quite full length. The last category, long, represents all of the UMIs that are comprised of full
length transcripts (roughly 50% of the UMIs). The estimates from the remaining categories were
made with Equation 3.2 using roughly 6% of the UMIs each.
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Figure 3.7: The estimated mean rUMI based on the GC content of the transcript is shown for
all transcripts (left panel) and for full length transcripts (right panel) in the top 10 cells. rUMI
appears roughly quadratically related to GC content for all transcripts, although this relationship
does not hold for full length transcripts. AT/GC imbalances appear to result in smaller estimates of
mean rUMIs. Full length transcripts tend to have smaller AT/GC imbalances and a slightly larger
proportion of GC (Figure 3.8).
pattern. Note that the λ̂ values estimated for the full length reads are smaller than those from all
UMIs; this follows from the higher proportion of one rUMIs found in Figure 3.4 for the full length
reads. In addition, the full length reads tend to have smaller AT/GC imbalances and higher propor-
tions of GC (Figure 3.8). We suspect that these characteristics may explain the differences between
the two panels of Figure 3.7; the larger number of bases with which the full length transcripts are
normalized may also contribute to differences in both the GC characteristics and the relationship
between GC and rUMI.
Second, we examine the relationship between rUMI and the GC content in the first half of a
given transcript in Figure 3.9. Note that the GC content of the first half of a transcript contributes
to the GC content of the entire transcript in Figure 3.7. Here, however, we observe a stronger
quadratic relationship, with lower estimated rUMI occurring for an imbalance in AT/GC both for
all transcripts and for full length transcripts, suggesting that the composition of the first bases of a
transcript influences the technical biases that a UMI captures.
The relationship between rUMI and the proportion GC content in the second half of the tran-
script exhibited less clear patterns (Figure 7.1). Thus, it appears that the composition of the bases
in the first half of the transcript is driving the relationship between the GC content of the full
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Figure 3.8: The relationship between average length of a UMI and the average proportion GC. The
length categories are repeated from Figure 3.6. The full length UMIs have the highest proportion
GC content and the smallest AT/GC imbalance.
Figure 3.9: The estimated mean rUMI based on the GC content in the first half of the transcript
is shown for all transcripts (left panel) and for full length transcripts (right panel) in the top 10
cells. A quadratic pattern is observed in both panels, with an AT/GC imbalance corresponding to
a smaller average rUMI. Note that GC content in the first half of the transcript contributes to 50%




We further examine how the base pair composition of the transcript contributes to rUMI with
measures of the specific sequence of the transcript. We consider a sliding window of length two
for each transcript, recording the set of two base pairs in that window and defining this as a two-
some. Note that with four bases, there are sixteen options for two-somes. We then calculate the
proportion of a given two-some for the transcript. For UMIs with multiple reads, we summarize
the proportion of a two-some with the mean proportion for each of the reads.
Figure 3.10 displays plots for the two-somes that exhibit the strongest relationships with rUMI;
see Section 7.1.2 for additional figures and discussion. The AT, CT, TA, and TT two-somes show
the strongest relationships with rUMI for all transcripts, while the AA and GC two-somes show the
strongest relationships with rUMI for the full length transcripts. The lack of overlap between two-
somes with strong patterns between all transcripts and full length transcripts does provide some
hesitation as to the applicability of these results to all situations.
3.4.2.4 Other Variables
We consider the relationship between rUMI and other variables, with no especially interesting
patterns observed, in Section 7.1. Other variables explored include the proportion of guanine
and cytosine in the cellular barcode, the first base of the cellular barcode, the last base of the
cellular barcode, the proportion of guanine and cytosine in the molecular barcode, the first base
of the molecular barcode, and the last base of the molecular barcode. We selected these particular
variables due to their known relationships with amplification biases, in the case of GC content,
and their location before the transcript. We had suspected that features located at the beginning
of a read may contribute to technical effects associated with amplification or sequencing biases.
However, we observed no clear relationships between rUMI and these particular variables.
Additionally, we fit a generalized linear model to predict rUMIs based on a combination of
variables considered here. See 7.3 for a discussion of this model and its findings.
3.5 Discussion and Conclusions
In this chapter, we have motivated the use of rUMI as a measure of technical effects in scRNA-seq
data. Specifically, we describe some of the technical effects that rUMI could reasonably capture.
We introduce a zero-truncated Poisson distribution to model the rUMI distribution. We propose an
estimator for the λ parameter from a zero-truncated Poisson distribution. We continue developing
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Figure 3.10: The estimated mean rUMI is shown based on the average proportion of the specified
two-somes in transcripts. The two-somes in the top two rows (AT, CT, TA, and TT) are calculated
from all transcripts in the top 10 cells, while the two-somes in the bottom row (AA and GC) are
calculated from the full length transcripts in the top 10 cells. Average levels of these two-somes
have higher average rUMI, while enrichment or depletion of these two-somes results in lower
average rUMI.
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this estimators and discuss additional estimators in Chapter 4. We have explored how biological
gene and barcode characteristics are related to rUMI, suggesting that the GC content of a transcript
is especially informative in estimating rUMI.
The rUMI measure summarizes the amount of deduplication that has occurred for a given tran-
script. Additionally, rUMI captures technical biases associated with specific genes and transcripts.
Specifically, since rUMI measures the number of copies of a single transcript, it also can also sug-
gest characteristics stemming from the gene or the UMI that indicate a transcript is more likely to
be read. Thus, we can identify technical biases that increase the likelihood of a given transcript
being read, and, conversely, infer characteristics that reduce the likelihood of a transcript being
read.
Further work is needed to fully address how we anticipate our findings could be incorporated
into later downstream analyses. We envision that these results could provide meaningful insights
in multiple ways.
The estimated λ̂ for rUMI indicates how reliably detectable a given gene is, with higher esti-
mated rUMI measures indicating that the UMI is more likely to be captured in scRNA-seq data.
Genes with specific characteristics, like a proposed range of proportion GC in the first 75 bp iden-
tified from Figure 3.9, could be identified as genes that might be especially reliably detectable.
We may need to adapt gene-level characteristics from the transcript-level ones used in our current
approach by removing introns or assuming that the first 75 bp of a gene are preserved in order to
identify these genes.
The methods that we have applied to this scRNA-seq data could be applied to other scRNA-seq
data with UMIs. We anticipate that our results may be generalizable, although some characteristics
may capture technical effects differently based on the experiment. Estimating λ̂ for rUMI and
modeling rUMI based on the experimental results to be analyzed could further inform how reliably
detectable a given gene is within an experiment.
A list of reliably detectable genes or a model to identify reliably detectable genes could be
applied to later analyses and normalizations in a variety of ways. First, we could evaluate zeros
occurring in scRNA-seq data based on how reliably detectable the gene is. We may be able to infer
whether zeros from a given gene are systematic, semi-systematic, or stochastic based on features
of the gene. Additionally, reliably detectable genes may be selected as genes that experience
fewer technical biases and can serve as features for clustering or cell type identification. Finally,
we proposed in Chapter 2 that the cytosolic ribosomal genes appear to be proportionally stable.
We may be able to use the characteristics of reliably detectable genes to further refine the list of
proportionally stably expressed genes, as an additional desirable characteristic of stably expressed
genes is reliable detection.
Conversely to the methods described above, we could apply these results to identify genes that
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are particularly unreliably detected. We may choose to remove unreliably detected genes from
later analyses or adjust their measurements in some way. By recognizing that the gene expression
is unreliable, we may be able to remove some of the technical effects from the data. Through this
extrapolation of unreliable detection, we may also be able to identify zeros in scRNA-seq data
that we believe are biologically unexpressed or that we suspect are zero due to some technical
effects. This information could be incorporated into later analyses. Specifically, data imputation
and normalization methods have been proposed both for the zero counts of scRNA-seq data [Huang
et al., 2017] and for all genes using pools of cells [Dijk et al., 2017; Lun et al., 2016].
Before applying our reliably detectable characteristics to many datasets, we recommend assess-
ing the generalizability of our results in additional datasets. We have applied the analysis discussed
here to 20 additional cells from the same experiment, observing similar patterns regardless of cell
size; see Section 7.2. We could apply these same methods to cells or reads from any scRNA-seq
experiments with UMIs, providing robust support for the generalizability of the results presented
here. One can imagine tissue, platform, or experimental protocol differences that change the exact
technical effects captured by the rUMI measure. If the same general results are found in multiple
datasets, then one set of genes may be proposed as reliably detectable. If different results oc-
cur, then it may be advisable to repeat the analysis to identify characteristics specific to the given
experiment.
Different experimental conditions could occur for a number of reasons. The experiment itself
may apply different protocols to different tissue types, depending on the experimental purpose.
Often, one of the experimental conditions the scientist has to balance is the cost and the amount
of new information. Sequencing costs are often one of the most expensive, and thus, scientists try
to reduce cost and redundant information in the form of duplicated reads. It is often desirable to
have an rUMI with many low values, indicating that little redundant information was purchased.
Statistically, however, the low rUMI values indicate low sampling of the transcripts, and thus less
certainty about conclusions. Experimenters strive to have low experimental waste (small values
for rUMIs) while obtaining the maximum amount of information.
One possible byproduct of low experimental waste is the high proportion of zero counts in
scRNA-seq data. Zero counts indicate that no copies of a gene were measured in a given cell
but were measured in a different cell. These zero counts are not necessarily problematic and may
arise from different causes, including the gene not being expressed in the cell, the transcripts not
being assigned to a UMI, or the transcripts assigned to a UMI not being read, i.e. 0 rUMIs. The
first scenario is not problematic but is biologically accurate. The second scenario may arise due
to technical biases but information to evaluate these biases is not available currently. The third
scenario, however, can be addressed with the rUMI measure described here. Specifically, genes
that have characteristics of lower rUMIs, like an imbalance of AT and GC bases, may have less
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reliable detection and thus less trustworthy zero counts. These factors may be uniformly applied to
all transcripts from a given gene, or differentially applied based on other factors. More work needs
to be undertaken to evaluate how helpful the rUMI measure could be clarify the zero counts, as we
suspect that a large portion of zero counts result from the first or second scenarios.
Our hope is that our measure of reliable detection using rUMIs in conjunction with the pro-
portional stability of the cytosolic ribosomal genes will result in a procedure that can be used to
normalize scRNA-seq data in a more systematic and intentional manner.
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Chapter 4
Zero-truncated Distribution Models of Reads per UMI
4.1 Abstract
Single-cell RNA-sequencing (scRNA-seq) experiments measure the RNA transcripts present in a
single cell but are subject to many technical effects. We proposed reads per unique molecular
identifier (rUMI) as a way to measure technical effects in a scRNA-seq experiment in Chapter 3.
One prominent feature of the rUMI statistic is that it cannot take zero values. In this chapter, we
extend the statistical motivation and methods for rUMI estimation and explore characteristics of
plausible zero-truncated distributions that the rUMIs could follow. Specifically, we examine three
different special case models for the rUMIs. We define five estimators: the maximum likelihood
estimator for the three data generating models (zero-truncated Binomial, zero-truncated Poisson,
and zero-truncated Negative Binomial), a moment-based estimator from a zero-truncated Poisson
distribution, and a robust estimator from a zero-truncated Poisson distribution. We then examine
various features of these estimators, including their performance under different data generating
schemes. Finally, we apply these estimators to data obtained from a scRNA-seq experiment. We
specifically examine the proportion GC in the transcript as described in Chapter 3 and the expres-
sion level of the gene as discussed by Hicks et al. [2018] in relation to the estimated mean rUMI
for each of the five estimators.
4.2 Introduction
Single-cell RNA-sequencing (scRNA-seq) measures gene expression at the cellular level. Various
factors have been proposed as affecting the measurements, including both technical and biological
features [Hicks et al., 2018]. Understanding the technical effects of a scRNA-seq experiment could
improve data normalization, informing the analytical processes applied to data.
We previously introduced a measure of some of the technical effects associated with scRNA-
seq experiments, taking advantage of information recorded from an experimental innovation, Unique
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Molecular Identifiers (UMIs). UMIs are barcodes that tag transcripts, marking duplicate reads re-
sulting from amplification. UMIs provide a basis for deduplication of reads and reduce biases in
the measurements, including those resulting from transcript length and proportion of GC bases
[Phipson et al., 2017; Kivioja et al., 2012; Islam et al., 2014]. We propose that additional infor-
mation can be gleaned from the deduplication step and suggested calculating the reads per UMI
(rUMI) to measure technical effects in Chapter 3. We suspect that rUMI may summarize some of
the technical effects due to amplification and sequencing. Indeed, Tung et al. [2017] explore the
conversion of reads to molecules at the cellular level to assess sources of variation in scRNA-seq
experiments, finding evidence of both biological and technical sources of variation. In contrast, we
explore the reads per UMI at the molecular level.
With rUMIs measured from a given experiment, we can estimate features of rUMIs, including
the proportion of zero rUMIs, based on various distributional assumptions. The proportion of zero
rUMIs specifically estimates the proportion of the population of molecules that attach to beads
that are captured in the experimental sample. Stegle et al. [2015] and Kolodziejczyk et al. [2015]
estimate that the proportion of molecules captured in the experiment could be 60 − 95%. In fact,
experimenters are pleased with a distribution of rUMIs that have many low values, as sequencing is
expensive and duplicate reads provide redundant experimental information. Statistically, however,
that same high proportion of zero rUMIs indicates less confidence in conclusions, as they are
drawn from a smaller portion of the population. Biases in detection of genes can also affect the
conclusions drawn from scRNA-seq experiments. Particularly, Hicks et al. [2018] suggest that
genes that are lowly expressed are more likely to result in zero rUMI measures than genes that are
highly expressed within a cell, i.e. that the expression level of a gene affects the probability that a
molecule of that gene is captured in the reads.
The distribution of observed rUMIs is composed of integer values of one or more, with a
maximum possible value determined by amplification. Because we cannot observe 0 rUMIs, we
examine zero-truncated (ZT) distributions, or distributions that do not allow values of zero. Typical
observed rUMI distributions have a large proportion of values of one and two, with a long right
tail of higher values. Based on these characteristics, ZTBinomial, ZTPoisson, and ZTNegative
Binomial distributions are reasonable to propose. The Binomial distribution is appropriate based
on the underlying scientific processes of amplification and sequencing. The Poisson distribution
is often suggested as an approximation to the Binomial distribution, while the Negative Binomial
distribution relaxes the assumption from the Poisson distribution that the mean and variance are
equivalent.
In this chapter, we further explore the rUMI statistic used to measure technical effects pro-
posed in Chapter 3 and possible underlying ZT distributions. In particular, our goals are to: (1)
develop estimators for the unobserved proportion of zero rUMIs in a given sample, (2) evaluate
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our estimators for their theoretical properties, and (3) apply our estimators to simulated and real
data.
We particularly aim to predict the proportion of zero rUMIs from characteristics of the molecule.
With this information in hand, we are better able to estimate the sampled proportion of transcripts
and to inform normalizations applied to scRNA-seq data. We suspect that transcript characteristics
may result in different proportions of 0 rUMIs. Thus, our estimators should be capable of being
applied to the entire sample of rUMIs or to subsets of the sample based on specific molecular
characteristics. This chapter focuses on the development and properties of the estimators.
4.3 Statistical Framework
4.3.1 Notation
Let M denote the number of molecules, i.e. transcripts, within a sample. Let Ni for i ∈ 1, . . . ,M
denote the number of copies of the transcript following amplification within that same sample.
Further, let pi denote the probability for a given copy of molecule i to be captured in the sequencing
reads.1 Then, we can consider Xij the indicator that the j th copy of molecule i is captured, with
P(Xij = 1) = pi. We further denote the number of reads for molecule i as Ri =
∑Ni
j=1Xij .
The Ri for i ∈ 1, . . . ,M is then the true distribution of rUMI for this given sample. However,
we only observe Ri when it takes a non-zero value. We denote Zi as an indicator of molecule i
being captured in the reads, and Ci as the observed Ri value when Zi = 1. When Zi = 0, Ci is
undefined. Further, let n =
∑M
i=1 Zi, or the sample size of the observed Ci.
We are interested in estimating the probability that a molecule is not captured in the reads, πi =
P(Ri = 0), which is equivalent to 1− E(Zi). We will denote the true probability P(Rk = 0 | k ∈
K) as π,K and any estimators as π̂,K where K is an index for some group of molecules, providing
the flexibility for estimators to be evaluated for different groups of molecules. The estimators that
we develop can be applied to all of the observed reads in a scRNA-seq experiment or to subsets
of the reads, capturing the relationship between attributes of molecules and the probability that a
molecule will be included in the final reads, i.e. P(Zi = 1). In other words, we use features of
our observed rUMI distribution (or a subset of it) to estimate the proportion of molecules that are
unobserved in the reads.
1Since all Ni copies of molecule i are identical, barring any amplification errors, it is assumed that pi is equivalent
for all Ni copies.
55
4.3.2 Special Cases
Special Case 1: Binomial Distribution Suppose that pi = p0 ∀ i, i.e. that the probability of
capturing any molecule is the same for all molecules. In addition, suppose that Ni = N0 ∀ i, i.e.
that amplification is equally efficient for all molecules. Additionally, we assume that N0 is finite.






and Ci a ZTBinomial one. Thus, for
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Special Case 2: Poisson Distribution Again, suppose that the probability that any given molecule
is captured is equivalent for all molecules, i.e. pi = p0 ∀ i, and that amplification is equally ef-
ficient for all molecules, i.e. Ni = N0 ∀ i. As N0 → ∞ and p0 → 0, letting N0p0 → λ, then
Ri ∼ Poisson(λ), and Ci ∼ ZTPoisson(λ). Thus, for c ∈ 1, 2, 3, . . .,




In this scenario, π = e−λ.
Special Case 3: Negative Binomial Distribution Suppose that Ni = N0 ∀ i again, but that
pi is no longer identical but drawn from a Gamma
(
α, β = αN0
λ0
)
distribution. The pi distribution





when λi = N0pi. For a given λi, suppose N0 → ∞,





and Ci ∼ ZTNB with the
same parameters. Thus, for c ∈ 1, 2, 3, . . .,






(α + λ0)c[(α + λ0)α − (α)α]
. (4.3)






Above, we have proposed three distributions that could plausibly motivate the distribution of
rUMIs. Moments for these three distributions can be found in Section 8.1.
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4.4 Estimators
4.4.1 Approach for Extrapolation
Our primary goal is estimating the unobserved probability that a molecule is not captured, i.e.
πi, based on the rUMI values that we do observe. We are attempting to estimate an unobserved
quantity that falls outside the range of observed values, resulting in an extrapolation problem with
all of its related challenges.
We propose above three plausible forms of the probability density function for the distribution
of our observed C. Our approach is to identify estimators by imposing assumptions that imply a
distributional form to the data generating process (e.g., Binomial, Poisson, or Negative Binomial).
We then can take advantage of the assumed form to predict π,K from the existing information.
The distributional form of the probability density function is needed to calculate π̂,K . However,
while we can assess the fit of our estimated probability density function to the observed distribution
of C, this information in fact does not provide an assessment of the accuracy of the estimated
probability of 0. We are extrapolating about the proportion of rUMIs that are 0, a value that falls
outside of the observable range of rUMIs.
Because we are extrapolating, we anticipate that the rUMIs measured with small values will
be more informative in predicting the probability of 0 rUMIs. Specifically, the small values of
rUMI, i.e. 1s and 2s, are closer to 0 rUMIs than larger values, i.e. 6s and 7s, and therefore are
plausibly better able to predict 0 rUMIs. The overall fit of the assumed distribution to the observed
distribution provides evidence of a good representation of the observed data but does not indicate
an accurate estimate of the probability of 0 rUMIs. In fact, a good fit of our estimated distribution
to the observed distribution could also indicate overfitting to the data. Therefore, we anticipate
well-fitting local probability estimates to be more informative of the accuracy of our estimator
compared to an overall goodness of fit.
4.4.2 Estimator Definitions
We are primarily interested in estimating π,K := P(Rk = 0 | k ∈ K), the probability that a
given transcript is not included in the final sample, i.e. 0 rUMI, for some group K of molecules.
Secondarily, we can also estimate λ,K , which is equivalent to the mean rUMI based on the distri-
bution of rUMIs including the unobserved zeros proposed in each of the Special Cases in Section
4.3.2. Below, we provide estimators for λ,K ; we examine the performance of their corresponding
probability estimates π̂,K in Section 4.4.3 as described in Section 4.3.2.
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4.4.2.1 Estimator 1: Moments Estimator
Under Special Case 2, C ∼ ZTPoisson(λ). Ordinarily, for a method of moments estimator, we
would solve for λ after equating the sample mean with E(C) in Table 8.2. However, this equation
does not provide a closed form estimator for λ. Therefore, we consider the first two moments
together. Note that E(C2) = E(C)(1 + λ), or equivalently that Var(C) = E(C)[1 + λ − E(C)].















4.4.2.2 Estimator 2: Robust Estimator






In other words, λ̂2 is 2 times the ratio of the number of rUMIs equal to two to the number of rUMIs
equal to one. Taking the expectations of the indicators and assuming a ZTPoisson distribution
simplifies λ̂2 to λ and provides the motivation for this estimator.
We describe λ̂2 as a robust estimator, because it is the only estimator that does not involve the
sample moments. Specifically, λ̂2 is not influenced by large observed rUMI values through the
mean in the same way as the other four estimators.
4.4.2.3 Estimator 3: Poisson Maximum Likelihood Estimator
The maximum likelihood estimator, λ̂3, from the ZTPoisson distribution is
λ̂3 =
{





There is no closed form solution for the MLE of the ZTPoisson distribution. Note that the max-
imum likelihood estimator λ̂3 is equivalent to the standard method of moments estimator and is
calculated only using the sample mean, unlike λ̂1, which is calculated from the sample mean and
the sample variance.
Note that if the sample consists entirely of 1 rUMI, then we set λ̂3 = 0 and π̂3 = 1.
4.4.2.4 Estimator 4: Binomial Maximum Likelihood Estimator
We next consider the maximum likelihood estimator from Special Case 1, the ZTBinomial distri-











Since N0 is an additional parameter, we consider the possible values of N0 when identifying the
maximum likelihood. We scan over integer values for N0 ranging from the maximum of the
sample to 4,096 (212, selected based on the number of amplification rounds) or another large
value, calculating the λ̂4 and corresponding likelihood function for each N0. We then select the






. Note that in terms of λ, this is again the standard method of moments estimator
but for the ZTBinomial distribution and assuming that N0 is known.
Note that if the sample consists entirely of 1 rUMI, we set λ̂4 = 0, and π̂4 = 1.
4.4.2.5 Estimator 5: Negative Binomial Maximum Likelihood Estimator
We finally consider the maximum likelihood estimator from Special Case 3, the ZTNegative Bino-
mial distribution. Again, there is no closed form solution for the estimator, and λ̂5 is
λ̂5 =
{







We optimize the likelihood function over values of α ranging from 1 × 10−9 to 200 and the cor-






. Note that λ̂5 is again the standard method of moments estimator but for
the ZTNegative Binomial distribution assuming α is known.
Note that if the sample consists entirely of 1 rUMI, we set λ̂5 = 0, and π̂5 = 1.
4.4.3 Estimator Properties
4.4.3.1 Estimator 1: Moments Estimator
Our first estimator is given in Equation 4.4. For this estimator, we derive the asymptotic bias and
variance using Taylor expansions in Section 8.2.1.




















The moments of our three special cases in Tables 8.1 to 8.3 can be combined with Equations
4.9 and 4.10 to calculate the asymptotic biases and variances of the λ̂1 in terms of the parameters.
Under a ZTPoisson distribution (Special Case 2), λ̂1 is asymptotically unbiased and Var(
√
nλ̂1)→
(λ + 2)(1 − e−λ). The asymptotic bias is − λ
N0
with data drawn from a ZTBinomial distribution
(Special Case 1) and is λ
α
with data from a ZTNegative Binomial distribution (Special Case 3).
If the true model is a ZTPoisson distribution, the MSE for λ̂1 will approach 0 as the sample size
grows. However, if the true model is either ZTBinomial or ZTNegative Binomial, the asymptotic
biases will prevent the MSE from approaching 0.
4.4.3.2 Estimator 2: Robust Estimator
The formula for the robust estimator contains two variables. Observe that the variables
∑
I(Ci =
1) ∼ Binomial(n,P(C = 1)) and
∑
I(Ci = 2) ∼ Binomial(n,P(C = 2)) where n =
∑
Zi. With









nλ̂2)→ 4P(C = 2)
(
1− 2P(C = 2)
P(C = 1)2





We can solve for the asymptotic bias and variance by substituting values for P(C = 1) and P(C =
2) into the above formulas for various sampling schemes.
When C ∼ ZTPois(λ), P(C = 1) = e−λλ
1−e−λ and P(C = 2) =
e−λλ2
2(1−e−λ) . Therefore, λ̂2 is







2− 6e−λ − 2λ2e−λ + 6e−2λ + 4λ2e−2λ − 2e−3λ − 2λ2e−3λ




Note again that the MSE for λ̂2 under a ZTPoisson distribution will approach 0 as the sample
size increases. Additionally, under a ZTPoisson distribution, ARE(λ̂1, λ̂2) → eλ as λ → ∞
(Figure 4.1). Thus, λ̂1 and λ̂2 perform similarly for small λ, but λ̂1 is more efficient for larger λ.
The asymptotic biases for λ̂2 are
λ(λ−1)









drawn from a ZTNegative Binomial distribution. A description of the asymptotic variances can be
found in Section 8.2.2 and can be generated by combining Equation 4.12 and probabilities from
Equations 4.1 and 4.3.
4.4.3.3 Estimator 3: Poisson Maximum Likelihood Estimator
λ̂3 is the maximum likelihood estimator (mle) from the ZTPoisson distribution. We can obtain the
asymptotic distribution of the mle from the Fisher Information for the correctly specified distribu-






λ(eλ − 1)(1− e−λ)
eλ − 1− λ
)
.
Note that although λ̂3 approaches the variance specified by the Cramér-Rao Lower Bound, it will
not attain it.
The asymptotic relative efficiencies for combinations of λ̂1, λ̂2, and λ̂3 are shown in Figure
4.1. When data are drawn from a ZTPoisson distribution, the robust estimator λ̂2 has the largest
variance, while the maximum likelihood estimator λ̂3 has the smallest.
The asymptotic bias and variance for the ZTBinomial and ZTNegative Binomial cannot be
calculated. Estimates from simulations are discussed in 4.5.1.
4.4.3.4 Estimator 4: Binomial Maximum Likelihood Estimator
If we assume that N0 is fixed and known in the ZTBinomial distribution, we can obtain the asymp-






λ(N0 − λ)2(NN00 − (N0 − λ)N0)2
NN0+10 [(N0 − λ)(NN00 − (N0 − λ)N0)− λN0(N0 − λ)N0 ]
)
.
We cannot calculate the asymptotic biases and variances for the ZTPoisson or ZTNegative
Binomial cases directly; we discuss estimates from simulations in Section 4.5.1. We additionally
discuss estimates from simulations where N0 is unknown and data are drawn from a ZTBinomial
distribution in Section 4.5.1.
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Figure 4.1: The asymptotic relative efficiencies of the ZTPoisson-based estimators λ̂1 (moment-
based estimator), λ̂2 (robust estimator), and λ̂3 (maximum likelihood estimator).
4.4.3.5 Estimator 5: Negative Binomial Maximum Likelihood Estimator
If we assume that α is fixed and known in the ZTNegative Binomial distribution, we can obtain the







λ[(α + λ)α − αα]2
α(α + λ)α−1[(α + λ)α − αα]− λαα+2(α + λ)α−2
)
.
We discuss the estimated asymptotic biases and variances from simulations for the ZTPoisson
and ZTBinomial cases and for the ZTNegative Binomial case when α is unknown in Section 4.5.1.
4.5 Simulations
4.5.1 Estimator Performances
We simulate data generated according to each of the three special cases described in Section 4.3.2.
For each generated sample, we apply our five estimators and record the values of λ̂ and π̂. The
following tables summarize the results from these simulations.
Tables 4.1 and 8.4 provide the MSEs for π̂ and λ̂ respectively for each of the five estimators
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Distribution MSE ×103
λ Family π π̂1 π̂2 π̂3 π̂4 π̂5
0.1
ZTP 0.905 0.001 0.001 0.001 0.010 0.011
ZTB 0.904 0.580 0.497 0.552 0.013 0.568
ZTNB 0.906 0.550 0.430 0.510 0.511 0.024
0.4
ZTP 0.670 0.001 0.002 0.001 0.006 0.008
ZTB 0.656 7.168 3.640 5.942 0.002 6.130
ZTNB 0.683 5.850 2.326 4.510 4.520 0.016
1.5
ZTP 0.223 0.001 0.003 0.000 0.001 0.005
ZTB 0.153 29.603 0.161 16.018 0.000 16.591
ZTNB 0.280 15.975 0.582 9.549 9.569 0.003
Table 4.1: Mean squared error (multiplied by 103) for the estimated probability of 0 from three
data generating processes. 500 samples of size 250,000 were collected. π represents the true
probability of zero for each of the three distributions. N = 4 for the ZTB distribution, and α = 4
for the ZTNB distribution.
and from each of the three data generating processes. We consider three different true λ values of
0.1, 0.4, and 1.5. We set N0 = 4 for the ZTBinomial and α = 4 for the ZTNegative Binomial case.
We simulate a sample of size 250,000 from each of the zero truncated models as specified, taking
500 repeated samples. Note that the true π in Table 4.1 varies for the different data generating
functions.
The estimators derived from the correctly specified model often perform the best in terms of the
MSE. When the true distribution of observed rUMIs is ZTPoisson, π̂2 performs worse than π̂1 and
π̂3, the other two estimators derived from the ZTPoisson distribution. When the true distribution
is ZTBinomial, the estimator derived from the ZTBinomial distribution, π̂4, performs the best,
followed by π̂2. The best performing estimator when the true distribution is ZTNegative Binomial
is π̂5, the estimator derived from the ZTNegative Binomial distribution, again followed by π̂2.
We examine how adjusting the additional parameter in the ZTBinomial distribution (N ) and
in the ZTNegative Binomial distribution (α) affects the five estimators. We continue generating
samples of size 250,000 as before, but we simulate 100 samples instead of 500. We set λ = 0.4
for these simulations.
Table 4.2 indicates that π̂4 seems to perform best when N is small followed by π̂2. As N
increases, the ZTBinomial distribution begins to more closely match the ZTPoisson distribution.
When N ≤ 64, the MSE of π̂4 is smaller than the other estimators; when N = 256, however,
π̂3 and π̂1, estimators derived from the ZTPoisson distribution, have surpassed the estimator from
the correctly specified distribution, likely due to a close resemblance of the ZTBinomial to the
ZTPoisson distribution at this point.
Table 4.3 presents MSE estimates for π̂ based on data generated from ZTNegative Binomial
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N π π̂1 π̂2 π̂3 π̂4 π̂5
2 0.640 31.918 19.235 27.831 0.002 28.126
4 0.656 7.147 3.622 5.922 0.002 6.110
8 0.663 1.706 0.807 1.385 0.013 1.485
16 0.667 0.414 0.191 0.334 0.010 0.386
64 0.669 0.027 0.013 0.022 0.009 0.037
256 0.670 0.003 0.002 0.002 0.007 0.010
1024 0.670 0.002 0.002 0.002 0.007 0.010
Table 4.2: Mean squared error (multiplied by 103) for the estimated probability of 0 from ZT-
Binomial data with varying N . 100 samples of size 250,000 were collected.
α π π̂1 π̂2 π̂3 π̂4 π̂5
1 0.714 70.248 22.353 50.771 50.814 0.016
5 0.681 3.833 1.560 2.974 2.982 0.011
20 0.673 0.254 0.110 0.200 0.202 0.016
50 0.671 0.041 0.019 0.033 0.033 0.010
70 0.671 0.023 0.013 0.019 0.021 0.010
100 0.671 0.012 0.008 0.010 0.015 0.006
Table 4.3: Mean squared error (multiplied by 103) for the estimated probability of 0 from ZTNeg-
ative Binomial data with varying α. 100 samples of size 250,000 were collected.
distributions with varying α. The estimator from the correctly specified model, π̂5 performs best for
the α considered in this table followed by the robust π̂2. The advantages of both of these estimators
decrease as α increases and the ZTNegative Binomial distribution more closely approximates the
ZTPoisson one.
Figures 8.1 to 8.7 display the estimated asymptotic biases and variances for our five estimators
under the three different data generating functions along with the theoretical results obtained in
Section 4.4.3. In particular, we note that the MSEs only approach 0 when the estimator is unbiased.
Additionally, we note that the estimation of the second parameter for λ̂4 and λ̂5 do affect the
asymptotic biases and variances and quite substantially.
Our simulations indicate that the robust estimator π̂2 performs well across most situations,
although another estimator can typically outperform it. Generally, the performance of π̂2 does not
rely on a specific underlying distribution or set of parameters to perform well. The performance of
the other estimators, however, do rely on the underlying distribution. The corresponding tables for
the λ̂ estimates can be found in Tables 8.4 to 8.6.
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Distribution MSE ×103
Collision Family π π̂1 π̂2 π̂3 π̂4 π̂5
0.1%
ZTP 0.670 0.002 0.002 0.001 0.007 0.007
ZTB 0.656 4.469 2.563 3.779 0.941 4.287
ZTNB 0.683 5.964 2.380 4.597 4.608 0.014
0.5%
ZTP 0.670 0.010 0.006 0.008 0.010 0.008
ZTB 0.656 4.510 2.422 3.776 0.382 3.932
ZTNB 0.683 6.322 2.464 4.839 4.850 0.022
1%
ZTP 0.670 0.029 0.015 0.023 0.025 0.011
ZTB 0.656 4.444 2.331 3.703 0.145 3.858
ZTNB 0.683 6.813 2.663 5.207 5.218 0.017
2%
ZTP 0.670 0.111 0.054 0.088 0.089 0.008
ZTB 0.656 4.448 2.354 3.719 0.129 3.875
ZTNB 0.683 7.791 2.962 5.889 5.901 0.029
Table 4.4: Mean squared error (multiplied by 103) for the estimated probability of 0 from data
with varying levels of collisions. 100 samples of size 250,000 were collected. True generating
parameters are λ = 0.4, N = 4, and α = 4.
4.5.2 Modifications to Special Cases
The special cases described in Section 4.3.2 present idealized versions of data generating functions.
However, we suspect that various perturbations to these special cases may exist. We simulate
data with various modifications and perturbations, evaluating the five estimators in each of these
situations.
4.5.2.1 Collisions
We define a collision as the situation where two distinct molecules attach to identical UMIs.
Note that there are two classes of collisions: observable and unobservable, depending on
whether the transcripts originate from different or the same gene, respectively. From the data
generated by Green et al. [2018], we can identify observable collisions as two (or more) molecules
aligned to different genes with the same UMI.
We observe in Chapter 3 that UMIs are not in fact perfectly unique using scRNA-seq drop-seq
data [Green et al., 2018]. Therefore, we use the gene as an additional characteristic to distinguish
two distinct molecules that attach to identical UMIs in the data in an observable collision. In fact,
it is not surprising that there are some observable collisions, as there are 65,536 distinct molecular
barcodes and 244,272 molecules in the top 10 cells.
We simulate data assuming that unobserved collisions occur for some portion of the UMIs.
Our data generating process is modified from that described in Section 4.5.1. First, we simu-
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late our non-collision data from a ZTPoisson (λ), ZTBinomial (N0, λN0 ), or ZTNegative Binomial
(α, λ
α+λ
) distribution, as before. We simulate our collision data from a ZTPoisson (2λ), ZTBi-
nomial (2N0, λ2N0 ), or ZTNegative Binomial (α,
2λ
α+2λ
) distribution, respectively. We take random
samples of size 250,000 from the non-zero values simulated from the non-collision and collision
data, mixed at the specified collision rate. We simulate 100 samples of 250,000 UMIs in total. We
set λ = 0.4, N0 = 4, and α = 4.
Table 4.4 displays the simulation results for data including unobserved collisions occurring
at different rates, with Table 8.7 displaying the analogous results for the respective λ̂ estimators.
The true π is calculated for the non-collision data. The results from Table 8.7 are similar to those
described in Section 4.5.1. Specifically, the estimator derived from the correct data generating
function typically has the best performance of the five estimators considered; the robust estimator
π̂2 typically follows this estimator in performance. As the collision rate increases, the ZTPoisson
distribution resembles the ZTNegative Binomial distribution. π̂5 based on the ZTNegative Bino-
mial distribution then has the best performance followed by π̂2. Generally, the advantage of the
robust π̂2 increases as the collision rate increases.
We chose our simulated collision rates from observed collision rates in scRNA-seq data [Green
et al., 2018]. Specifically, we first estimated the probability that two randomly selected molecules
share a UMI. From this estimated probability, we calculated the number of effective UMIs as
37,452. Specifically, the probability that two randomly selected molecules share a UMI from our
observed data is 2.67 × 10−5. If our UMIs were perfectly random, this corresponds to 37,452
possible UMIs.
The unobserved collision rate depends on the expression level of individual genes. Therefore,
we increased the observed expression level of a gene from our data three-fold to more closely
approximate the true expression level of the cell before the estimated loss of molecules prior to
assignment of UMIs (Table 4.6). We simulated the assignment of molecules to one of the effective
UMIs based on our expression level of a gene. We estimate that unobserved collisions occur for
approximately 0.1% of the UMIs in the data collected by Green et al. [2018]. Almost all of our
simulated collisions had two molecules assigned to one UMI, while a handful had three molecules
assigned to the same UMI. Table 8.7 is the analogous table to Table 4.4 for λ̂.
4.5.2.2 Corruption
We noted in Chapter 3 that the observed distribution of rUMIs had a long right tail, extending to
9 rUMI. This characteristic in particular led us to develop the robust estimator λ̂2 that would not
be affected by the right skew. Therefore, we were interested in representing this skewness in our
simulated data. We first considered modifying our simulated data with collisions with our primary
collision rate estimated from real data. From the simulated samples of rUMIs with collisions in
66
Table 4.4, 1 of the 400 ZTPoisson samples had 9 rUMIs and 47 of the 400 ZTNegative Binomial
samples had 9 or 10 rUMIs. We therefore considered a direct perturbation of the data generating
procedure.
We artificially require 25 of the 250,000 simulated molecules to have rUMIs of 6-10 with
respective probabilities of 5%, 35%, 20%, 35%, and 5%. We refer to the artificially high rUMIs as
corrupt rUMIs. For the remaining 249,975 molecules, we simulate them according to a ZTPoisson,
ZTBinomial, or ZTNegative Binomial distribution with λ = 0.4, N0 = 16, and α = 4. For this
simulation, we increased N0 from 4 to 16 to reduce the separation between the simulated rUMIs
and the corrupt rUMIs for the ZTBinomial data.
Table 4.5 shows that π̂2 is one of the most consistently well performing estimators, although
it is not always optimal. Table 8.8 represents an analogous table to Table 4.5 for the respective λ̂
estimates.
Distribution MSE ×103
λ Family π π̂1 π̂2 π̂3 π̂4 π̂5
0.1
ZTP 0.905 0.024 0.001 0.002 0.002 2.888
ZTB 0.905 0.002 0.030 0.021 0.021 3.290
ZTNB 0.906 0.791 0.431 0.565 0.566 1.851
0.4
ZTP 0.670 0.011 0.002 0.002 0.002 0.231
ZTB 0.667 0.299 0.191 0.304 0.282 0.391
ZTNB 0.683 6.245 2.322 4.604 4.615 0.090
1.5
ZTP 0.223 0.001 0.003 0.000 0.001 0.005
ZTB 0.207 1.402 0.027 0.800 0.003 0.930
ZTNB 0.280 16.056 0.581 9.579 9.600 0.003
Table 4.5: Mean squared error (multiplied by 103) for the estimated probability of 0 from three
data generating processes with corruption (N0 = 16 and α = 4). 500 samples of size 250,000
were collected.
4.6 Sertoli Cell Drop-seq Data
We apply our five estimators to the data described in Chapter 3. Table 4.6 provides a summary
of the results. The bottom two rows of Table 4.6 calculate the five estimators without taking into
account the observable collisions. In other words, the top two rows use the gene as a deduplication
factor, while the bottom two rows only use the cellular and molecular barcode to deduplicate the
UMIs. The observable collisions change the estimates quite substantially. Unobserved collisions
could additionally affect the estimates.
We noted in Chapter 3 that there was a relationship between λ̂ and the GC content of a transcript
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Estimator 1 Estimator 2 Estimator 3 Estimator 4 Estimator 5
λ̂ 0.4757 0.3804 0.4408 0.4409 (4096) 0.2228 (0.882)
π̂ 0.6215 0.6836 0.6435 0.6434 0.8198
λ̂ 1.2788 0.7424 1.0468 1.0470 (4096) 0.5173 (0.695)
π̂ 0.2784 0.4760 0.3511 0.3509 0.6793
Table 4.6: The estimated λ̂ and associated probabilities from the Sertoli cell sample. The top two
rows are calculated from the sample using gene as a deduplication factor while the bottom two
rows do not use gene. For estimators 4 and 5, the N̂0 and α̂ associated with the MLE are provided
in parentheses along with the λ̂ value.
(Figure 3.7). We have provided an extension of this figure in the left panel of Figure 4.2, where we
estimate the λ̂ for each of our five estimators. The numbers in the figure represent the estimator
used to calculate the given estimate; in other words, the 1 in the figure corresponds to λ̂1, the 2 to
λ̂2, and so on. The size of the estimators appear consistent with the full sample estimates in Table
4.6. We observe a similar shape for each of the five estimators, indicating that there does appear to
be a relationship between the rate of 0 rUMIs and the GC content of a transcript.
The λ̂ estimates in Figure 4.2 are different for most of the estimators; in fact, the associated
π̂ vary from 59.0% to 88.2% (Figure 8.10); see Figures 8.8, 8.9, 8.11, and 8.12 for analogous
estimates calculated for twenty additional Sertoli cells. The robust estimator is often near the
middle in terms of the estimates. We also note that λ̂3 and λ̂4 are very near each other; this is
in part due to the large N̂ , which makes the estimated Binomial distribution very similar to the
Poisson distribution.
Because π̂ is extrapolated, it is difficult to know which estimator provides the best estimate.
From simulations, we have observed that λ̂2 tends to have a low MSE under different data generat-
ing processes. Additionally, λ̂2 is not the most extreme estimate of the five options. However, the
scientific understanding is the same regardless of the estimator selected. An imbalance of AT and
GC in the transcript has lower mean rUMI than transcripts that are more balanced.
4.7 Hicks (2018) Revisited
Hicks et al. [2018] describe technical variability that occurs in scRNA-seq data by studying mul-
tiple datasets. As part of their investigation, they examine how scRNA-seq data compare to bulk
RNA-seq data performed on the same sample of cells. Ignoring any technical effects, one would
expect the average of the gene expression across the cells in scRNA-seq data would closely ap-
proximate the measured expression from bulk RNA-seq data. Reproducing work performed by
Shalek et al. [2013], they generate a graph comparing the average of logs of the single-cell and
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Figure 4.2: The estimated λ̂ values for each of the five estimators. The left panel shows an ex-
tension of Figure 3.7, estimating λ based on the GC content of the transcript. The right panel
estimates λ based on the expression level of the gene.
bulk profiles with the difference between the logs of the single-cell and bulk profiles (Figure 2 and
Figure S11). They then fit a smoothed line to the data by binning the values on the x-axis and
calculating the mean difference for a given bin, identifying that lowly expressed genes have larger
measurements in bulk data than in their single-cell counterparts.
Hicks et al. [2018] in essence argue that genes that are lowly expressed are more likely to ex-
perience 0 rUMI than genes that are highly expressed. In other words, Hicks et al. [2018] indicate
that the probability that a given molecule is captured is not equally likely for all molecules but
depends on the expression level of that gene. We use a different approach to assess this statement;
we estimate the λ parameter after subsetting the molecules into categories based on the expression
level of their associated gene. The right panel of Figure 4.2 displays the estimates based on the
expression level of the gene. We note a general trend that as the expression level of a cell increases,
so does the λ̂ regardless of the estimator. The corresponding π̂ estimates from these λ̂ differ by
less than 4.5%; in fact, the π̂2 estimates differ by 2.1%. For comparison, the π̂ based on the GC
content have a range of at least 9% for all estimators.
Our results appear to be somewhat discordant with those obtained by Hicks et al. [2018].
Therefore, further investigation is warranted to understand these two results jointly.
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4.8 Discussion
In this chapter, we have developed estimators for rUMI, furthering the work introduced in Chapter
3. We describe the characteristics of the distribution of rUMIs, including that rUMIs take pos-
itive integer values. We provide motivation and details surrounding three plausible distributions
for rUMIs, the ZTBinomial, ZTPoisson, and ZTNegative Binomial distributions. Additionally,
we propose five estimators derived from these three distributions: maximum likelihood estimators
for each of the three distributions, a closed form methods-based estimator for the ZTPoisson dis-
tribution, and a robust estimator for the ZTPoisson distribution. We study asymptotic properties
of these estimators both theoretically where obtainable and through simulations to understand the
biases and uncertainties associated with the estimators.
No one estimator has universally ideal properties. In particular, the estimators derived from the
true data generating function appear to perform best based on the MSE. However, the robust λ̂2
typically is optimal after the estimator from the correctly specified model. We examine perturba-
tions to the data generating processes, including collisions and corruption. Collisions occur when
two or more transcripts are assigned to the same UMI; these collisions are unobservable when the
transcripts originate from the same gene. Corruption modifies a given distribution by sampling a
portion of observations from high values for rUMI that are unlikely to be sampled from the data
generating distribution by chance. When high levels of unobserved collisions or corruption are
present, λ̂2 tends to perform better than most of the other estimators.
We apply our estimator to scRNA-seq data in two ways. First, we examine the relationship of
the five different estimators with the GC content of the transcript. The five estimators identify the
same pattern between the mean rUMI and the GC content of the transcript; that is, we see that an
imbalance in GC and AT in a transcript results in smaller estimated mean rUMIs. The values for
the estimates do differ between the five estimators. Additionally, we note that Hicks et al. [2018]
claim that genes that are more lowly expressed result in smaller mean rUMIs based on joint single-
cell and bulk RNA sequencing experiments. We apply that claim to our data, estimating the mean
rUMI based on the expression level of the gene. We note a modest increase in mean rUMI for
more highly expressed genes, although our observed increase is not consistent with the size of the
effect noted by Hicks et al. [2018]. This inconsistency warrants further investigation.
We note that our five estimators do in fact provide different values for the estimates in Table
4.6 and in Figure 4.2. The variability of the five estimators seems inconsistent with the MSEs
calculated in Tables 8.4 to 8.8. Specifically, the difference between λ̂1 and λ̂5 seems quite large
relative to the observed MSEs. Thus, it appears that our simulated data does not represent the
observed distribution of rUMIs well, as the MSEs from our simulated data are not consistent with
those that would result from our observed estimates in Figure 4.2. An area for further exploration
70
is to identify differences between our simulated data and the observed distribution or to consider
additional perturbations to simulated data in order to generate MSEs that appear consistent with
the variability in our observed estimators.
Overall, we were interested in estimating the true proportion of zero rUMIs. This extrapolation
problem can be informed by the observed rUMI distribution but cannot be assessed purely based
on the observed data. As discussed in Chapter 3, we are interested in estimating the technical
biases present in an experiment through the rUMI measure. The proportion of zero rUMI serves as
a way to quantify some of the technical biases in a scRNA-seq experiment. Specifically, we would
like to predict the proportion of molecules not included in our reads based on various molecule and
gene characteristics. We have demonstrated that we can estimate the unobservable proportion of
zero rUMI using five different estimators. These estimators can be applied to different datasets to




In this work, we have presented two approaches to address biases that are present in scRNA-
seq data. Both of these two approaches work to identify biases with characteristics that can be
leveraged in normalization procedures to help data more accurately represent what we expect to be
the true biological gene expression at the cellular level.
In Chapter 2, we first define different notion of stably expressed genes at the cellular level.
In particular, we define these notions based on the true biological nature of the cell rather than
the measurements obtained from scRNA-seq experiments. Absolute stability indicate that a gene
is expressed with approximately the same number of transcripts in each cell, while proportional
stability and stability in concentration indicate that a gene is expressed approximately constantly
with respect to either the total RNA content of the cell or the cell volume, respectively. Genes
exhibiting different notions of stability are capable of capturing different types of technical effects.
The different notions of stability can define different types of differential expression. However,
scRNA-seq data is subjected to many technical effects, and identifying stably expressed genes can
be challenging. Specifically, different normalizations can obscure or highlight different types of
stably expressed genes. Therefore, we examine multiple scRNA-seq datasets to identify genes that
appear to be generally stably expressed, organizing our analysis by studying sets of genes that
are associated with cellular structures. We motivate our analysis by proposing a data generating
model for the measured expression based on the true expression and technical factors and interpret
our results through this model. We find that the set of cytosolic ribosomal genes is enriched with
proportionally stable genes, based on both scRNA-seq and bulk GTEx data, indicating the poten-
tial for their use in downstream normalization procedures. We also generate a database of gene
information that can be used to further evaluate and refine sets of stably expressed genes based on
scRNA-seq and GTEx data.
In Chapter 3, we approach scRNA-seq data by considering the number of reads sequenced for
each unique molecular identifier (UMI). The rUMI measure can be applied to scRNA-seq data in
two primary ways: as a way to estimate the unobserved probability that a given molecule will have
0 rUMIs, i.e. be excluded from the reads due to technical loss, and as a way to identify genes
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that are reliably detected, i.e. have a large estimated rUMI value. We begin by proposing a zero-
truncated Poisson distribution to model the rUMI distribution and an estimator for the associated
λ. We create categories for a variable, calculating our λ̂ for each category and observing its re-
lationship with rUMI. We find that the proportion of guanine and cytosine in the first half of the
transcript is particularly informative in estimating mean rUMI, with an imbalance resulting in less
reliable detection. We consider additional characteristics, including transcript length, two-somes,
base composition of the cellular barcode, and base composition of the molecular barcode, with less
informative results.
In Chapter 4, we extend and strengthen the theoretical framework and results introduced in
Chapter 3. Specifically, we motivate potential rUMI distributions with assumptions about the
underlying processes that contribute to the sample rUMIs, suggesting three possible underlying
zero-truncated distributions. We then propose five estimators both for the distributional parameters
and for the probability of 0 rUMIs resulting from the parameters. We aim to extrapolate the true
proportion of 0 rUMIs due to technical loss from our observed rUMI distribution both generally
and as a function of characteristics of the molecules. We study the properties of our five estimators
under different data generating functions and perturbations. The robust estimator derived from the
ZTPoisson distribution and calculated as 2 times the ratio of the number of 2 rUMIs to the number
of 1 rUMIs performs well under all data generating processes although is rarely the optimal choice
in any given situation based on its MSE. Finally, we estimate the probability of technical loss based
on the observed expression level of the gene with our five estimators, finding that there does appear
to be a marginal increase in technical loss of molecules among lowly expressed genes.
The removal of biases from scRNA-seq data is challenging. However, we have generated a list
of proportionally stably expressed genes that can assist in normalizing the data to remove technical
effects associated with cell size. In addition, we have identified characteristics that are indicative of
reliable detection, and conversely can be estimated as indicative of unreliable detection. These two
findings could be used for normalization separately or could be combined to generate a list of genes
that appear to be both proportionally stably expressed and reliably detected, two characteristics that
are both favorable for genes to be used in normalizations.
While these results are encouraging, and indeed illuminating for scRNA-seq experiments, there
are additional avenues of research stemming from these biologically motivated results.
First, we have proposed a set of proportionally stable genes, but we have thus far struggled
to identify any genes that appear absolutely stable in scRNA-seq data. We attempted to leverage
the stable “expression” of external spike-ins as described in Chapter 2 but found that the spike-ins
appeared more stable than endogenous measurements. We interpret this as indicative of stronger
technical effects present in endogenous genes compared to the external spike-ins, i.e. a more
variable t than u from Model 2.1. Thus, we would like to consider leveraging other endogenous
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genes that have been suggested as biologically plausible to be absolutely stably expressed. In
addition, we would like to further refine the cellular structures that we have considered. Some
of the structures are quite large, and subsetting them into smaller categories may provide more
specific gene sets. These provide two preliminary approaches as a starting point for identifying
absolutely stably expressed genes.
Second, we have proposed an approach to quantify reliable detection of genes with rUMI by
estimating the proportion of 0 rUMIs. How reliably detectable a gene is could inform our interpre-
tation of gene expression measurements, indicating which measurements are more accurate. We
would like to further explore the rUMI measure in additional scRNA-seq protocols, experiments,
and tissue types to assess the generalizability of our given estimators. The approach could be ap-
plied to any scRNA-seq data with UMIs, but similar results across multiple experiments would
suggest that similar technical effects are present across all scRNA-seq experiments. Additionally,
we proposed frameworks for the true distribution of rUMIs. We would like to continue explor-
ing the fit of various distributions with different perturbations to the true data to model it more
accurately, as well as identifying the conditions that are optimal for each of the estimators.
Finally, we would like to explore exactly how best to incorporate cytosolic ribosomal genes
and other stably and reliably expressed genes into normalization procedures. We would like to
present a method to remove some technical biases from scRNA-seq data. While we have made
preliminary advances towards this end goal by defining sets of genes that can be applied to existing
normalization methods, we would like to understand how well these procedures work in adjusting
scRNA-seq data for technical effects.
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Chapter 6
Supplement: Stably Expressed Genes
6.1 Additional Single-Cell Figures
We provide in this section figures from scRNA-seq data that are referenced in Chapter 2 (Figures
6.1 to 6.6). These figures provide additional details to support conclusions drawn in Chapter 2.
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Figure 6.1: Histograms of the average correlations of each gene with the ERCC total over the six
C1 datasets, with comparisons between the gene set of interest and the remaining genes. Note that
the x-axis ranges from -0.15 to 0.275.
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Figure 6.2: Continuation of Figure 6.1
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Figure 6.3: Histograms of the average correlations of each gene with the adjusted cell total over
the six C1 datasets, with comparisons between the set of genes of interest and the remaining genes.
Note that, unlike Figures 6.1 and 6.2, the x-axis ranges from -0.05 to 0.95.
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Figure 6.4: Continuation of Figure 6.3.
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Figure 6.5: Continuation of Figure 2.9.
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Figure 6.6: Continuation of Figure 2.12.
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6.2 Gene Summaries
6.2.1 Structural Annotation Dictionary
Our structural annotation dictionary combines a list of human genes from Ensembl’s Biomart with
the Gene Ontology Consortium’s (GO) information on genes gathered with mygene in R [Wu
et al., 2013; Xin et al., 2016]. Gene names, not Ensembl identifiers, were used.
The query through mygene returns the top matches from GO for a given gene name. We
retained only the top match. Any genes not identified from GO were removed. The biological
process, molecular function, and cellular component were returned from GO. Each of these fields
could have no values or multiple values.
We considered the 1,629 unique cellular components returned for mapping the genes into ten
broad cell structure (or location) categories. The cellular categories that were mapped to the cell
structures were identified with a combination of text matching and review. First, terms associated
with the structure of interest were identified with the text term in the second column of Table 6.1.
The cellular components that matched that text string were reviewed for appropriate fit. Cellular
component categories that did not seem to fit were removed with the text string(s) specified in
the third column of Table 6.1. The cell structures we consider are: nucleus, endoplasmic retic-
ulum, Golgi apparatus, cytoplasm, membrane, mitochondria, ribosome, mitochondrial ribosome,
ribonucleoprotein complex, and cytosolic ribosome.
The mapping was not one-to-one. In fact, each cellular component could be mapped to no
structure, one structure, or multiple structures. Some categories were nested, with the cytosolic
ribosome being a subset of the ribosome. In addition, each gene had zero to 41 cellular components
as annotated by GO, with 75% of genes having four or fewer cellular components.
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Table 6.1: Structural Annotation Dictionary Criteria





Endoplasmic reticulum reticu sarcoplasmic, cortical
Golgi bodies Golgi vesicle





















Mitochondria ribosome mitochond, ribosom
Ribonucleoprotein complex nucl, ribonucleoprotein
Cytosolic ribosome ribosom, cytosolic
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6.2.2 Cytosolic Ribosomal Genes
The 103 cytosolic ribosome genes from the Fluidigm C1 scRNA-seq datasets are:
COA1, DDX3X, EIF2A, EIF2AK4, EIF2D, EIF4G1, FXR2, GEMIN5, LARP 4, MRPL1,
MRPL4, MRPS18A, MRPS18C, MARPS5, NAA10, NHP2, NUFIP1, RPL10, RPL10A, RPL11,
RPL12, RPL13, RPL13A, RPL14, RPL15, RPL17, RPL18, RPL18A, RPL19, RPL21, RPL22,
RPL22L1, RPL23, RPL23A, RPL24, RPL26, RPL26L1, RPL27, RPL27A, RPL28, RPL29, RPL3,
RPL30, RPL31, RPL32, RPL34, RPL35, RPL35A, RPL36, RPL36A, RPL36AL, RPL37, RPL37A,
RPL38, RPL39, RPL39L, RPL4, RPL41, RPL6, RPL7, RPL7A, RPL7L1, RPL8, RPL9, RPLP0,
RPLP1, RPLP2, RPS10, RPS11, RPS12, RPS13, RPS14, RPS15, RPS15A, RPS16, RPS18, RPS19,
RPS2, RPS20, RPS21, RPS23, RPS24, RPS25, RPS26, RPS27, RPS27A, RPS27L, RPS28, RPS29,
RPS3, RPS3A, RPS4X, RPS5, RPS6, RPS7, RPS8, RPS9, RPSA, RSL1D1, RSL24D1, SURF6,
UBA52, ZNF622
The 89 cytosolic ribosome genes from the GTEx dataset are:
APOD, DDX3X, EIF2A, EIF2AK4, FXR2, GEMIN5, HBA1, HBA2, MCTS1, MRPL4,
MRPS18A, MRPS18C, MRPS5, NAA11, NHP2, NUFIP1, PPARGC1A, RPL10A, RPL10L,
RPL11, RPL12, RPL13, RPL13AP3, RPL14, RPL17, RPL18, RPL18A, RPL19, RPL21, RPL22,
RPL23, RPL23A, RPL24, RPL26, RPL26L1, RPL27, RPL27A, RPL28, RPL29, RPL30, RPL31,
RPL32, RPL36, RPL36A, RPL36AL, RPL37, RPL37A, RPL38, RPL39, RPL39L, RPL39P5,
RPL3L, RPL41, RPL7, RPLP1, RPLP2, RPS10, RPS10P5, RPS11, RPS12, RPS13, RPS14,
RPS15, RPS16, RPS17, RPS18, RPS19, RPS20, RPS23, RPS25, RPS27, RPS27A, RPS27L,
RPS28, RPS29, RPS3A, RPS4X, RPS5, RPS6, RPS7, RPS8, RPS9, RPSA, RSL1D1, RSL24D1,
SNU13, SURF6, UBA52, ZNF622
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6.3 Stability Measures
Here, we provide mathematical formulations for the stability measures described in Sections 2.4.4
and 2.4.5.
Let i represent a gene, j a dataset, k a cell, G some set of genes, and ci,j,k the expression
recorded for gene i in cell k in dataset j. Let sG,j be a vector representing the sum of the set
of genes G; in other words, sG,j,k =
∑
i∈G ci,j,k is the kth entry in the vector sG,j . Conversely,
let s−G,j be a vector representing the sum of the genes not contained in the set of genes G, or
s−G,j,k =
∑
i/∈G ci,j,k is the kth entry of the vector s−G,j .
The correlations that serve as a measure of absolute stability for a given gene i and a given
dataset j are calculated by rERCC,i,j = cor(log(ci,j + 1), log(sE,j)) where E is the set of ERCC
spike-ins. The overall measure of absolute stability for gene i is rERCC,i = 16
∑6
j=1 rERCC,i,j .
The correlations that serve as a measure of proportional stability for a given gene i, a given
dataset j, and a given cell structure with gene set S are defined as rS,i,j = cor(log(ci,j+1), log(s−S,j)).
The overall measure of stability for gene i is rS,i = 16
∑6
j=1 rS,i,j .
We calculated an additional measure of proportional stability that was comparable across all
genes. This uses an unadjusted cell total, unlike the measure of proportional stability defined
above that uses a cell total adjusting for a given structure. sj is a vector where sj,k =
∑I
i=1 ci,j,k;
that is, we sum over all of the genes for a given cell. The measure for a given dataset is ri,j =




6.4 Absolute Stability from Individual ERCC spike-ins
We examine the ERCC measurements separately. Within an experiment, ERCC spike-ins are in-
troduced in the same manner and are subjected to the same technical protocols. However, they
are intentionally designed to have different characteristics, providing the ability to capture differ-
ent technical effects. In our analysis, we summed the ERCC spike-in measurements to capture an
overall technical effect.
We examine the correlations between individual ERCC spike-ins to assess the similarity of
the technical effects captured by the spike-ins. Figure 6.7 displays the strong correlations among
the spike-ins in GSE77288 compared to the remaining datasets. The pattern of expressions of the
ERCC spike-ins on the log scale are summarized in Figure 6.8. Higher expressions for GSE84686
are evident, as are some differences in the expression profiles across the six datasets.
Recognizing that the individual ERCC spike-ins may be capturing a variety of technical effects,
and that highly expressed ERCCs may dominate the ERCC total used in our analysis, we replace
the sum of the spike-in measurements with the median, a robust measure (Figures 6.9 and 6.10).
The correlations are calculated in the same manner as described in Chapter 2 with the median of
the ERCC measurements replacing the ERCC total, resulting in a correlation between the log of
the gene expression + 1 and the log of the median of the ERCC measurements + 1. The calculated
correlations are all less than 0.25 in absolute value. This suggests that regardless of the quantity
that summarizes the ERCC measurements, the correlations with gene expression will remain small.
It appears that there are limits to how well the ERCC measurements capture the technical effects
with respect to biological gene expressions, reducing their effectiveness in addressing questions of
absolute stability.
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Figure 6.7: The correlations of ERCC spike-in measurements within a dataset. The same set of 56
ERCCs that were measured in each of the six Fluidigm C1 datasets are included in this figure.
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Figure 6.8: The expression levels of ERCC spike-in measurements within each dataset. The same
set of 56 ERCCs that were measured in each of the six Fluidigm C1 datasets are included in each
of these plots.
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Figure 6.9: Histograms of the average correlations of each gene over the six Fluidigm C1 datasets
considered, with comparisons between the set of genes of interest and the remaining genes. This
figure is similar to Figure 6.1, but with the median of the log-transformed ERCC spike-in measure-
ments replacing the sum.
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Figure 6.10: Continuation of Figure 6.9.
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6.5 GTEx Features
6.5.1 Difference in Expression Profiles of Genes
In Chapter 2 we use SVD plots of the GTEx data to investigate the stability of different gene
sets. We interpret lack of clustering by cell type to indicate that gene expression is stable across
cell types. However, another possible explanation for lack of clustering by cell type would be the
existence of variation due to some other, stronger factor that dominates the SVD plot. To ensure
that the lack of separation is indeed due to stability of expression, we examine the IQR of gene
expression as a way to measure stability directly. In particular, we calculate, for each gene and for
each tissue type, the IQR of log-RPKM-adjusted expression. We can then compare the distributions
of these IQRs for the cytosolic ribosomal genes, the genes from Eisenberg and Levanon [2003], the
genes from Lin et al. [2019a], and other highly expressed genes. The IQRs provide a sense of how
stably expressed the given set of genes are within the tissue type, with smaller values indicating
more stable expression (Figures 6.11 to 6.16).
In general, it appears that the cytosolic ribosomal genes have small IQRs within tissues, indi-
cating that their differences between subtissue types are small. This does not discount the potential
for cytosolic ribosomal genes to have differences between tissue types; any tissue-specific depen-
dencies suggest caution to their later implementation in analyses that contain multiple tissue types.
Figure 6.11: The distribution in IQR of genes within the brain in the GTEx data.
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Figure 6.12: The IQRs for the expression of genes within adipose tissue samples.
Figure 6.13: The IQRs for the expression of genes within blood vessel samples.
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Figure 6.14: The IQRs for the expression of genes within esophagus samples.
Figure 6.15: The IQRs for the expression of genes within heart samples.
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Figure 6.16: The IQRs for the expression of genes within muscle samples.
Figure 6.17: The IQRs for the expression of genes within skin samples.
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6.6 Supplementary Table Description
We created a table that contains information for human genes, including structural annotations
and numerical summaries from our single-cell and GTEx analyses. The first ten columns contain
indicators for whether the gene was classified as a member of each of our structures; these names
are denoted as the full name of the structure followed by “ indicator”. The following two columns
contain indicators of membership of the gene sets published by Eisenberg and Levanon [2003] and
by Lin et al. [2019a] and denoted with the author names.
Summary statistics, including the mean, standard deviation, and correlation, for each single cell
dataset are calculated for the genes expressed in all six scRNA-seq datasets. The mean and standard
deviation of the log + 1 transformed expressions for each of the genes is calculated for each of
the datasets; these variables are denoted with the five digit GEO accession number (GSE#####)
followed by either a “mean” or “sd” suffix to denote the summary measure. The correlation with
the unadjusted cell total is also included for each dataset, as well as the mean unadjusted cell total
across the six datasets. Our analysis in Chapter 2 primarily looks at correlations with adjusted
cell totals; we provide the mean correlation across the six datasets for each gene with each of the
adjusted cell totals. These variables have the name “sc cormean less” followed by the name of the
structure removed during the cell total calculation.
Prior to analysis, the GTEx data is normalized according to an adjusted RPKM transformation.
The total number of reads for a given sample is calculated and divided by 1,000,000. Each indi-
vidual entry is then transformed with log ([entry + 1]/ total samples per million). Then, the mean
and standard deviation of each gene are calculated for each of the tissue types contained within
the data. F-statistics and their respective degrees of freedom are calculated for each of the tissue
types that contain subtissue types; these F-statistics are a measure of how differentially expressed
the gene is between the subtissue types. Note that genes that are stably expressed will have low
F-statistics. These variables are denoted with GTEx tissue type statistic, where the “tissue type”
and “statistic” are replaced with the appropriate designation; the options for the statistic are mean,
standard deviation, F statistic, or degrees of freedom. Note that we have removed the “Transformed
fibroblasts” from the Skin tissue type, as these were prepared differently than the other samples.
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Chapter 7
Supplement: Modeling Biases of Reads per UMI
7.1 Univariate Associations
7.1.1 Transcript Proportion of Guanine and Cytosine
We consider the proportion of GC content for various parts of the transcript in Section 3.4.2.2. Fig-
ure 3.7 displays the estimated rUMI parameter based on the mean proportion GC in the transcript,
and Figure 3.9 displays the estimated rUMI parameter based on the mean proportion GC in the
first half of the transcript.
We also considered the relationship between rUMI and the mean proportion GC content in the
second half of the transcript (Figure 7.1). We see that the variation of rUMI observed amongst the
full length transcripts is less than all transcripts. However, the shape of the relationship for the full
length transcripts appears quadratic, while the shape for all transcripts is indistinct.
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Figure 7.1: The estimated mean rUMI based on the GC content in the second half of the transcript
is shown for all transcripts (left panel) and for full length transcripts (right panel) in the top 10
cells. An AT/GC imbalance corresponds to a smaller average rUMI. The shape from the full length
transcripts appears quadratic, while the shape from all transcripts is indistinct. Note that together
with the proportion GC in Figure 3.9, the proportion GC in the full transcript can be calculated.
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7.1.2 Two-Somes
Two-somes are calculated to measure the detailed composition of a transcript. We define two-
somes as every possible permutation of two bases that could appear within a read. Note that with
four bases, there are sixteen possible two-somes. We calculate the two-somes by applying a sliding
window of length two to the read, recording the number of times each of the sixteen possible two-
somes occur; the number of two-somes for a read are one less than the length of the read. Thus,
we can calculate the proportion of a given two-some for a read with the length and the number of
two-somes.
Figures 7.2 and 7.3 display the relationship between the proportion of each of the twosomes
with the estimated mean rUMI. Note that these figures all have the same scale on the y-axis,
so the distributions are comparable in terms of estimated mean rUMI. We see that the strongest
relationships with rUMI occur with AT, CT, TA, and TT two-somes. Note that, with the exception
of CT, all of these two-somes consist of adenine and thymine bases and are from the same side of
the AT/GC divide. The remaining two-somes exhibited weaker relationships with rUMI.
We also consider the two-somes for the full length transcripts. Figures 7.4 and 7.5 are similar
to Figures 7.2 and 7.3 but calculated on only the full length transcripts. The full length transcripts
in general have smaller mean rUMIs, as described in Chapter 3 and evidenced by the reduced scale
of the y-axis. In addition, the patterns observed for full length transcripts generally appear weaker
than those for all transcripts. The AA and GC two-somes seem to have the strongest relationship
with rUMI. Again, the AA and GC two-somes occur on the same side of the AT/GC divide.
Note that the two-somes with the strongest relationships with rUMI do not seem to be preserved
across Figures 7.2 and 7.3 to Figures 7.4 and 7.5. Thus, we are hesitant to conclude that two-some
results are generalizable.
98
Figure 7.2: The relationship between two-somes calculated from all transcripts and λ̂ for rUMI.
Note that the scale of the y-axis is preserved across all plots. The clearest relationships seem to be
visible for the AT, CT, TA, and TT two-somes.
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Figure 7.3: Continuation of Figure 7.2.
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Figure 7.4: The relationship between two-somes calculated from full length transcripts and λ̂
for rUMI. Compared to Figure 7.2, we have removed those UMIs that do not have full length
transcripts. Note that the scale of the y-axis is smaller than in Figure 7.2 but is preserved across all
plots. The clearest relationships seem to be visible for the AA and GC two-somes.
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Figure 7.5: Continuation of Figure 7.4.
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7.1.3 Cells
We calculated the λ̂ for rUMI for each of the ten cells examined (Figure 7.6). There are variations
in the estimated mean rUMI for each cell, but the amount of variation is fairly small. The general
pattern of mean rUMI is preserved across all transcripts and full length transcripts. The first and
third largest cells do seem to have the smallest mean rUMI values.
Figure 7.6: The relationship between each of the cells and the estimated mean rUMI for all tran-
scripts (left panel) and for full length transcripts (right panel).
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7.1.4 Cellular Barcode
For this experiment, the UMI consists of 20 bp. Each cell has a 12 bp barcode to identify transcripts
originating from that cell. The cellular barcode allows researchers the ability to record the gene
expression at the cellular level. As the UMI is located near the beginning of the genetic material
during amplification and sequencing, we hypothesize that the cellular barcode may affect the rUMI.
Therefore, we consider various features of the cellular barcode and their relationships with the
estimated mean rUMI. Specifically, we examine the proportion GC in the cellular barcode, the first
base, and the last base of the barcode.
Figure 7.7 displays the relationship between the proportion GC content of the cellular barcode
with the estimated mean rUMI. We analyze ten cells, i.e. ten cellular barcodes, which reduces the
values that the proportion GC content in the cellular barcode takes. The ten cells in Figure 7.6
are summarized in three categories in Figure 7.7. No meaningful differences in mean rUMI are
calculated in Figure 7.7.
Figure 7.8 shows the relationship between the first and last base of the cellular barcode with the
estimated mean rUMI. Similar to Figure 7.7, the ten cells from Figure 7.6 are summarized in four
categories in Figure 7.8. Again, no meaningful differences in mean rUMI are calculated based on
the first or last base of the cellular barcode.
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Figure 7.7: The relationship between the proportion GC in the cellular barcode and the estimated
mean rUMI for all transcripts (left panel) and full length transcripts (right panel). With ten cellular
barcodes, we calculate three values for the proportion GC. The ten cells displayed in Figure 7.6 are
reduced to three categories. The estimated mean rUMI is similar for each of the groups considered
here.
Figure 7.8: The relationship between the estimated mean rUMI and the first base in the cellular
barcode (left panel) and the last base in the cellular barcode (right panel). The ten cells displayed
in Figure 7.6 are reduced to four categories for this figure. The estimated mean rUMI is similar for
each of the groups considered here.
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7.1.5 Molecular Barcode
The remaining 8 bp of the UMI compose a molecular barcode. The molecular barcode allows
researchers to follow a transcript through sequencing, identifying reads originating from the same
transcript and motivating deduplication of reads. In addition, we could not measure rUMI without
the molecular barcode.
Similar to the cellular barcode, we hypothesize that features of the molecular barcode may
be informative in estimating rUMI. Therefore, we examine the proportion GC (Figure 7.9) and
the first and last base (Figure 7.10) in the molecular barcode. Figure 7.9 indicates that molecular
barcodes consisting only of A and T result in lower mean rUMI; however, only 366 UMIs contain
only A and T compared to 2,986 UMIs containing only G and C (the next smallest group). Thus,
the uneven (and small) sample size for proportion GC in the molecular barcode may be driving the
small estimated mean rUMI for the AT-only molecular barcodes. No other meaningful differences
in estimated mean rUMI are observed in Figures 7.9 and 7.10.
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Figure 7.9: The relationship between the proportion GC in the molecular barcode and the estimated
mean rUMI for all transcripts (left panel) and full length transcripts (right panel). We are limited
to nine values for the proportion of GC in the eight bases of the molecular barcode. The estimated
mean rUMI is similar for each of the groups considered here except for those molecular barcodes
that consist of only adenine and thymine.
Figure 7.10: The relationship between the estimated mean rUMI and the first base in the molecular
barcode (left panel) and the last base in the molecular barcode (right panel). The four bases provide
the four categories for this figure. The estimated mean rUMI is similar for each of the groups
considered here.
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7.2 Results for Twenty Additional Cells
7.2.1 Data Characteristics
In addition to the 10 cells with the most UMIs, we considered 20 additional cells. We chose 10 cells
that had close to the median level of UMIs (1,369-1,383 UMIs/cell), and we chose 10 additional
cells that had gene expressions near the 80th percentile (6,951-7,174 UMIs/cell); we call these
groups of cells median and medium cells, respectively. We repeated a similar analysis on these
cells that we did on the 10 highly expressed cells. We present analogous figures here, as evidence
that the patterns we observe with the 10 highly expressed cells are typically preserved between
cells of different gene expression levels.
From the 10 medium cells, there were 91,943 reads stemming from 74,853 UMIs. The median
cells had 15,344 UMIs deduplicated from 18,691 reads. Figure 7.11 shows the distribution of
rUMIs for each of the sets of 10 cells with the medium cells on the left and the median cells on
the right. Note that, again, over 80% of the UMIs have a single read. The medium cells have a
maximum of 7 rUMI, while for the median cells 6 rUMI is the maximum. This is reduced from 9
rUMI in the highly expressed cells, although fewer UMIs contribute to these histograms.
The medium cells have a mean rUMI of 1.24 (sd=0.53, λ̂ = 0.37 based on all of the UMIs).
The mean of the median cells is 1.22 rUMI (sd=0.51; λ̂ = 0.36 based on all of the UMIs).
We again consider how the gene aids in deduplication of the UMIs, as discussed in Section
3.4.1 and specifically in Figure 3.5. Here, we see that the gene is not as helpful in distinguishing
distinct UMIs. As there are fewer UMIs stemming from a given cell compared to the top 10 cells,
it is reasonable to have fewer overlapping UMIs. The maximum rUMI does increase to 10 and 7
rUMI from 7 and 6 rUMI for the medium and median cells, respectively.
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Figure 7.11: Histograms of rUMI for the 10 medium (left panel) and 10 median (right panel) cells.
Compare to Figure 3.4.
Figure 7.12: Histograms of rUMI for the 10 medium (left panel) and 10 median (right panel) cells
with (in blue) and without (in yellow) using gene as an additional deduplication characteristic.
Compare to Figure 3.5.
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7.2.2 Univariate Associations
We recreate Figures 3.6 to 3.9, 7.1, 7.6, and 7.9 for the twenty additional cells in Figures 7.13
to 7.20. The results are largely similar to those found in the corresponding Figures from the 10
cells with the highest expression. It appears that the patterns noted for the 10 cells with high
expression are not a product of the cell size but are experienced by many cells. Note that fewer
UMIs are represented in the medium and median cells than in the 10 cells with high expression
shown earlier.
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Figure 7.13: Histogram of length (bp) of the transcripts (left panel) and estimated λ̂ based on
length (right panel) for the medium cells. Note that roughly 50% of the transcripts are full length
(151 bp) and represented by the one λ̂ estimate for long transcripts. Compare to Figure 3.6.
Figure 7.14: Histogram of length (bp) of the transcripts (left panel) and estimated λ̂ based on
length (right panel) for the median cells. Note that roughly 50% of the transcripts are full length
(151 bp) and represented by the one λ̂ estimate for long transcripts. Compare to Figure 3.6.
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Figure 7.15: Estimated λ̂ based on the mean proportion GC content of the transcript for the medium
(left panel) and median (right panel) cells. Compare to Figure 3.7.
Figure 7.16: Scatterplot of the relationship between the mean length (bp) and the mean propor-
tion GC content of the transcripts for the medium (left panel) and the median (right panel) cells.
Compare to Figure 3.8.
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Figure 7.17: Estimated λ̂ based on the mean proportion GC content in the first half of the transcript
for the medium (left panel) and the median (right panel) cells. Compare to Figure 3.9.
Figure 7.18: Estimated λ̂ based on the mean proportion GC content in the second half of the
transcript for the medium (left panel) and the median (right panel) cells. Compare to Figure 7.1.
113
Figure 7.19: Estimated λ̂ for each of the individual cells included in the 10 medium (left panel)
and 10 median (right panel) cells. Compare to Figure 7.6.
Figure 7.20: Estimated λ̂ based on the proportion GC content in the molecular barcode from the
medium (left panel) and the median (right panel) cells. Compare to Figure 7.9.
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7.3 Model for rUMIs
We filter to the UMIs with full length reads for model fitting purposes, resulting in a mean rUMI of
1.20 (sd = 0.50). Our estimated λ̂ from Equation 3.2 is reduced to 0.34 from 0.38 for all transcripts.
We predict rUMI with a general linear model from a zero-truncated Poisson family, based
on biological and analytical motivation. Recall that 0 rUMI cannot be recorded. We generated
analogous linear models, as well. Based on our findings in Section 3.4.2, we consider full sequence
proportion GC content, first half of sequence proportion GC content, AA two-somes, and GC two-
somes as predictors. Due to collinearity between the proportion GC content in the full sequence
and first half of the sequence, we selected the full sequence GC content based on interpretability.
The two-somes also exhibit collinearity, so we selected only the two-somes with the strongest
relationships observed in Figures 7.4 and 7.5.
The fitted model for rUMI is:
µ̂W (T, U, V ) = exp(−2.20 + 4.85T − 5.54T 2 + 2.72U − 13.35U2 + 3.60V − 20.15V 2), (7.1)
where W = rUMI, T = average proportion GC content of the UMI, U = average proportion
of AA two-somes of the UMI, and V = average proportion of GC two-somes of the UMI. The
analogous linear model has an R2 = 0.0011.
With over 80% UMIs recorded with 1 read (bottom panel of Figure 3.4), the fitted values for
this model are close to 1 (Figure 7.21). The average fitted rUMI increases from 1.205 to 1.216 for
UMIs with 1 read compared to multiple reads.
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Figure 7.21: Side-by-side boxplots of the fitted values based on Model 7.1 are shown for each
rUMI level. As rUMI increases, the fitted values generally increase. Note that the whiskers extend
to the maximum and minimum fitted values for each level. Outliers (defined as being beyond 1.5
times the IQR from Q1 or Q3) are present on the lower end for each of 1 to 5 rUMIs.
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Chapter 8
Supplement: Zero-truncated Distribution Models
8.1 Distribution Moments
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Table 8.1: Moments of the Zero Truncated Binomial Distribution










Table 8.2: Moments of the Zero Truncated Poisson Distribution
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Special Case 3: Negative Binomial Distribution For the ZTNegative Binomial distribution,
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Table 8.3: Moments of the Zero Truncated Negative Binomial Distribution
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8.2 Estimator Properties
We begin by deriving a general form of a multivariate Taylor expansion for fractions. We use this
throughout Sections 8.2.1 and 8.2.2.
Suppose that we have some general fraction of the form X1
X2
. Then, we can take a multivariate
Taylor expansion about the means of the two variables (µ1, µ2).
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. (8.1)
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Estimator 1, as defined in Section 4.4.2.1, is a moments-based estimator. For the derivations in this
Section, we use the right-side version of Estimator 1 in Equation 4.4.
































































Ci) = nE(C3i )− nE(C2i )E(Ci).
We can apply the moments from Tables 8.1 to 8.3 to the Equations above to calculate the
asymptotic biases and variances from different data generating functions.
Figure 8.1 shows simulated asymptotic biases and variances of λ̂1 with different data generating
procedures. The dotted lines represent the theoretical asymptotic biases and variances described
here, while the solid lines represent the simulated biases and variances for the given sample size.
We can additionally provide details about the asymptotic means and variances for π̂1. We
take a Taylor approximation of e−λ about E(λ̂1). Note that E(λ̂1) will change depending on the
distribution that C follows.
For the ZTPoisson distribution, π̂1 remains asymptotically unbiased, and the asymptotic vari-
ance is multiplied by e−2λ. When C ∼ ZTBin, the asymptotic bias is e−λ(e
λ
N0 − 1), and the





. When the data are drawn from a ZTNegative
Binomial distribution, the asymptotic bias of π̂1 is e−λ(e−
λ
α − 1), and the asymptotic variance is




Figure 8.1: Simulated biases and variances for λ̂1 for data drawn from ZTPoisson, ZTBinomial,
and ZTNegative Binomial distributions with λ = 0.4, N0 = 4, and α = 4. The dotted lines show
the theoretical results. 500 samples of 18 different sizes ranging from 10 to 100,000 were taken.
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8.2.2 Estimator 2
Estimator 2, as defined in Section 4.4.2.2, is a robust estimator. Note that the two variables used in
the estimator,
∑
I(Ci = 1) and
∑
I(Ci = 2), both follow a Binomial distribution with the same n
trials and probabilities of success of P(Ci = 1) and P(Ci = 2), respectively.
We take a multivariate Taylor expansion of λ̂2 around the means of (nP(Ci = 2), nP(Ci = 1)).















From Equation 8.4, the asymptotic variance of Estimator 2 is
Var(
√
nλ̂2)→ 4P(C = 2)
(
1− 2P(C = 2)
P(C = 1)2







I(Ci = 1) and
∑





I(Ci = 2)] = −nP(Ci = 1)P(Ci = 2).
We can apply the moments from Tables 8.1 to 8.3 to the general equations above to calculate
the asymptotic biases and variances from different data generating functions.













N40 (1 + λ− λ2 + 2λ4) +N30λ(−5− 2λ+ 2λ2 − λ3)
+N20λ
2(9 + λ− λ2) +N0λ3(−7− λ) + 2λ4
]
.
Figure 8.2 shows simulated asymptotic biases and variances of λ̂2 with different data generating
procedures. The solid lines represent the simulated biases and variances, while the dotted lines are
the theoretical biases and variances described here.
We can also calculate the asymptotic means and variances for π̂2. To do this, we take a Taylor
approximation of e−λ about E(λ̂2). Note that E(λ̂2) changes depending on the distribution of the
data.
When C ∼ ZTPois(λ), π̂2 remains asymptotically unbiased and the asymptotic variance of
λ̂2 is multiplied by e−2λ. If instead the true distribution of C is ZTBinomial, then the asymptotic
bias is e−λ(e
λ(1−λ)












, then the asymptotic bias of π̂2 is e−λ(e
λ(λ−1)
λ+α − 1). The asymptotic variance
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Figure 8.2: Simulated biases and variances for λ̂2 for data drawn from ZTPoisson, ZTBinomial,
and ZTNegative Binomial distributions with λ = 0.4, N0 = 4, and α = 4. The dotted lines show
the theoretical results. 500 samples of 18 different sizes ranging from 10 to 100,000 were taken.
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of λ̂2 is multiplied by e−2λ(1+
1−λ
λ+α) to calculate the asymptotic variance of π̂2.
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8.2.3 Estimator 3
The asymptotic bias and variance for π̂3 when C ∼ ZTPois(λ) can be estimated from the asymp-







eλ − 1− λ
)
.
Figure 8.3 shows simulated asymptotic biases and variances of λ̂3 with different data generating
procedures. Note that the theoretical bias and variance (dotted lines) could only be calculated when
the data are ZTPoisson. The simulated biases and variances are shown as solid lines.
Figure 8.3: Simulated biases and variances for λ̂3 for data drawn from ZTPoisson, ZTBinomial,
and ZTNegative Binomial distributions with λ = 0.4, N0 = 4, and α = 4. The dotted lines show
the theoretical results. 500 samples of 18 different sizes ranging from 10 to 100,000 were taken.
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8.2.4 Estimator 4
The asymptotic bias and variance for π̂4 can be estimated from the asymptotic distribution for λ̂4






λ(N0 − λ)2N0(NN00 − (N0 − λ)N0)2
N3N0−10 [(N0 − λ)(NN00 − (N0 − λ)N0)− λN0(N0 − λ)N0 ]
)
.
Figure 8.4 shows simulated asymptotic biases and variances (solid lines) of λ̂4 with different
data generating procedures. Note that the theoretical bias and variance (dotted lines) are calculated
only when the data are ZTBinomial and assuming a known N0. This assumption is violated when
estimating λ̂4, as N̂0 is also estimated.
Figure 8.5 shows simulated asymptotic biases and variances (solid lines) of λ̂4 if we assume
that N0 is known to be 4 with different data generating procedures. The difference between Figure
8.5 and Figure 8.4 shows how estimating the N0 changes the asymptotic biases and variances from
those calculated when N0 is known.
Figure 8.4: Simulated biases and variances for λ̂4 for data drawn from ZTPoisson, ZTBinomial,
and ZTNegative Binomial distributions with λ = 0.4, N0 = 4, and α = 4. The dotted lines show
the theoretical results. 500 samples of 18 different sizes ranging from 10 to 100,000 were taken.
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Figure 8.5: Simulated biases and variances for λ̂4 if we assume N0 = 4 is known for data drawn
from ZTPoisson, ZTBinomial, and ZTNegative Binomial distributions with λ = 0.4, N0 = 4, and
α = 4. The dotted lines show the theoretical results. 500 samples of 18 different sizes ranging
from 10 to 100,000 were taken.
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8.2.5 Estimator 5
The asymptotic bias and variance for π̂5 can be estimated from the asymptotic distribution for λ̂5






λα2α+1[(α + λ)α − αα]2
(α + λ)3α+1[(α + λ)α − αα]− λαα+1(α + λ)3α
)
.
Figure 8.6 shows simulated asymptotic biases and variances (solid lines) of λ̂5 with different
data generating procedures. Note that the theoretical bias and variance (dotted lines) are only cal-
culated when the data are ZTNegative Binomial and assume a known α. We violate the assumption
of a known α when estimating λ̂5 from simulated data, which contributes to the simulated variance
exceeding the theoretical one.
Figure 8.7 shows simulated asymptotic biases and variances (solid lines) of λ̂5 assuming that α
is known to be 4 with different data generating procedures. The difference between Figure 8.7 and
Figure 8.6 shows how estimating the α changes the asymptotic biases and variances from those
calculated when α is known.
Figure 8.6: Simulated biases and variances for λ̂5 for data drawn from ZTPoisson, ZTBinomial,
and ZTNegative Binomial distributions with λ = 0.4, N0 = 4, and α = 4. The dotted lines show
the theoretical results. 500 samples of 18 different sizes ranging from 10 to 100,000 were taken.
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Figure 8.7: Simulated biases and variances for λ̂5 if we assume α = 4 is known for data drawn
from ZTPoisson, ZTBinomial, and ZTNegative Binomial distributions with λ = 0.4, N0 = 4, and
α = 4. The dotted lines show the theoretical results. 500 samples of 18 different sizes ranging
from 10 to 100,000 were taken.
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8.3 Simulation Results
In Section 4.5, we provide Tables 4.1 to 4.3 to summarize the MSEs of the estimated probabilities
that a given molecule was not recorded, i.e. π̂. Tables 8.4 to 8.6 provide the corresponding MSE
values for the λ̂ estimators.
Additionally, we provide Tables 4.4 and 4.5 to demonstrate the MSEs of the estimated prob-
abilities under perturbations of the general data generating functions. Tables 8.7 and 8.8 provide
the corresponding MSEs for the λ̂ estimators.
Distribution MSE ×103
λ Family λ̂1 λ̂2 λ̂3 λ̂4 λ̂5
0.1
ZTP 0.001 0.001 0.001 0.011 0.012
ZTB 0.627 0.534 0.595 0.015 0.612
ZTNB 0.626 0.481 0.577 0.578 0.027
0.4
ZTP 0.003 0.005 0.003 0.010 0.013
ZTB 9.985 4.426 8.036 0.003 8.290
ZTNB 10.002 2.970 7.182 7.199 0.026
1.5
ZTP 0.012 0.053 0.009 0.011 0.027
ZTB 140.604 90.326 50.178 0.005 51.972
ZTNB 140.577 18.593 41.423 41.511 0.022
Table 8.4: Mean squared error (multiplied by 103) for the five estimators from three data generating
processes. 500 samples of size 250,000 were collected.N = 4 for the ZTB distribution, and α = 4
for the ZTNB distribution.
N λ̂1 λ̂2 λ̂3 λ̂4 λ̂5
2 39.963 22.457 34.356 0.004 34.719
4 9.952 4.399 8.005 0.005 8.258
8 2.505 0.998 1.956 0.020 2.098
16 0.625 0.239 0.482 0.016 0.557
64 0.043 0.018 0.032 0.013 0.055
256 0.005 0.005 0.004 0.011 0.016
1024 0.004 0.005 0.003 0.011 0.016
Table 8.5: Mean squared error (multiplied by 103) for the five estimators from ZTBinomial data
with varying N . 100 samples of size 250,000 were collected.
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α λ̂1 λ̂2 λ̂3 λ̂4 λ̂5
1 160.162 29.355 99.525 99.611 0.032
5 6.430 1.989 4.669 4.682 0.018
20 0.402 0.141 0.299 0.302 0.025
50 0.064 0.026 0.049 0.050 0.016
70 0.037 0.019 0.029 0.033 0.017
100 0.020 0.012 0.016 0.023 0.010
Table 8.6: Mean squared error (multiplied by 103) for the five estimators from ZTNegative Bino-
mial data with varying α. 100 samples of size 250,000 were collected.
Distribution MSE ×103
Collision Family λ̂1 λ̂2 λ̂3 λ̂4 λ̂5
0.1%
ZTP 0.004 0.005 0.003 0.012 0.010
ZTB 5.743 2.877 4.674 1.261 5.346
ZTNB 10.249 3.065 7.361 7.378 0.023
0.5%
ZTP 0.022 0.013 0.018 0.022 0.012
ZTB 5.786 2.616 4.646 0.504 4.849
ZTNB 11.027 3.217 7.861 7.879 0.035
1%
ZTP 0.065 0.033 0.051 0.055 0.017
ZTB 5.677 2.465 4.528 0.177 4.729
ZTNB 12.110 3.578 8.630 8.649 0.025
2%
ZTP 0.252 0.121 0.199 0.201 0.019
ZTB 5.681 2.497 4.550 0.136 4.752
ZTNB 14.309 4.134 10.086 10.107 0.028
Table 8.7: Mean squared error (multiplied by 103) for the five estimators from data with varying
levels of collisions. 100 samples of size 250,000 were collected. True generating parameters are
λ = 0.4, N = 4, and α = 4.
Distribution MSE ×103
λ Family λ̂1 λ̂2 λ̂3 λ̂4 λ̂5
0.1
ZTP 0.029 0.001 0.003 0.003 3.185
ZTB 0.002 0.032 0.022 0.022 3.609
ZTNB 0.919 0.482 0.643 0.645 2.089
0.4
ZTP 0.024 0.005 0.004 0.005 0.332
ZTB 0.422 0.238 0.430 0.399 0.554
ZTNB 10.859 2.962 7.376 7.393 0.140
1.5
ZTP 0.016 0.051 0.010 0.011 0.022
ZTB 8.323 2.705 2.815 0.016 3.277
ZTNB 142.149 18.627 41.774 41.862 0.022
Table 8.8: Mean squared error (multiplied by 103) for the five estimators from three data generating
processes with corruption (N0 = 16 and α = 4). 500 samples of size 250,000 were collected.
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8.4 Application to Sertoli Cells
We apply our five λ̂ estimators to the additional 20 cells (10 medium and 10 median) described
in Section 7.2. Figures 8.8 and 8.9 are analogous to Figure 4.2 for the medium and median cells,
respectively. Note that the medium and median cells appear to have similar relationships as the top
10 cells between the λ̂ estimates of rUMI and the proportion GC or expression level of a gene. We
also plot the corresponding π̂ estimates in Figures 8.10 to 8.12.
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Figure 8.8: Estimated λ̂ based on the proportion GC content in the transcript (left panel) and
expression level of the gene as calculated from the 10 cells (right panel) for the medium cells.
Compare to Figure 4.2.
Figure 8.9: Estimated λ̂ based on the proportion GC content in the transcript (left panel) and
expression level of the gene as calculated from the 10 cells (right panel) for the median cells.
Compare to Figure 4.2.
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Figure 8.10: Estimated π̂ corresponding to the λ̂ estimates in Figure 4.2 based on the proportion
GC content in the transcript (left panel) and expression level of the gene as calculated from the 10
cells (right panel) for the highly expressed cells.
Figure 8.11: Estimated π̂ corresponding to the λ̂ estimates in Figure 8.8 based on the proportion
GC content in the transcript (left panel) and expression level of the gene as calculated from the 10
cells (right panel) for the medium cells.
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Figure 8.12: Estimated π̂ corresponding to the λ̂ estimates in Figure 8.9 based on the proportion
GC content in the transcript (left panel) and expression level of the gene as calculated from the 10
cells (right panel) for the median cells.
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